{"study_id": 22447, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine associations between opioid use and kratom use, focusing on potential disparities by race/ethnicity and sexual orientation.", "results_summary": "The study found positive associations between opioid use and kratom use, with weaker associations among non-Hispanic Black and Hispanic participants compared to non-Hispanic White participants. Among those with opioid use disorder, bisexual participants had a lower probability of lifetime kratom use.", "population_specificity": "Nationally representative sample of individuals aged 18+ from the 2021 National Survey on Drug Use and Health (n=44,877 total; n=10,398 with past-year opioid use).", "effective_dosage": "Not available", "study_duration": "Not applicable (cross-sectional survey)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:46.490177+00:00"}
{"study_id": 22443, "supplement_id": 1261, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to understand how and why people use kratom for pain self-management, focusing on its effectiveness and safety.", "results_summary": "The study found that kratom provided significant pain relief, especially for those with chronic pain, and was frequently used for this purpose. Most participants reported no concerns about overuse or significant side effects, and stronger subjective effects of kratom were linked to lower pain levels.", "population_specificity": "Kratom consumers in the US, including those with and without chronic pain.", "effective_dosage": "Not specified", "study_duration": "15-day ecological momentary assessment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:48.197572+00:00"}
{"study_id": 22450, "supplement_id": 1261, "safety_score": "70", "efficacy_score": 80, "quality_score": 60, "study_goal": "The researchers aimed to review the current understanding of kratom's effects, its potential therapeutic uses, and its addictive profile.", "results_summary": "Kratom was found to have therapeutic benefits for pain, anxiety, depression, and substance addiction, with performance-enhancing effects. Consumption was generally well-controlled, with mild side effects, but risks increased with high doses or mixed use with other psychoactive substances.", "population_specificity": "Not specified (general use in Southeast Asia and increasing use in the western world).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Mixed consumption with other psychoactive substances was noted as a risk.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:48.313591+00:00"}
{"study_id": 22445, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 50, "quality_score": 40, "study_goal": "The researchers aimed to highlight the complexity of treating individuals who consume kratom, particularly those developing Kratom Use Disorder (KUD), and the need for individualized treatment approaches.", "results_summary": "The study found that kratom use can lead to dependence and challenges in detoxification, with varying treatment outcomes based on individual motivations and comorbidities. Successful interventions included methadone, clonidine, and naltrexone, while one case did not meet KUD criteria despite self-management for pain and anxiety.", "population_specificity": "Individuals consuming kratom, including those with Kratom Use Disorder (KUD) and those using it for self-management of pain and anxiety.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:48.889538+00:00"}
{"study_id": 22451, "supplement_id": 1261, "safety_score": "45", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to qualitatively examine kratom use experiences, motivations, effects, and consequences among social media users, focusing on product types and use practices.", "results_summary": "Kratom was perceived as effective for energy, pain relief, and reducing opioid/alcohol use, but notable negative experiences included physical dependence, perceived addiction, and product inconsistencies. Extracts were associated with higher reports of dependence and quitting.", "population_specificity": "Social media users (Reddit posters) discussing kratom use (demographics not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:50.872368+00:00"}
{"study_id": 22449, "supplement_id": 1261, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review current literature on kratom's toxicology, including its potential harms and benefits, to inform future risk and benefit assessments.", "results_summary": "The study found that kratom may have therapeutic potential as a reduced-harm alternative to opiates and for withdrawal treatment, but it also identified concerns about tolerance, addictive potential, and adverse effects among polysubstance users. Few studies provided clear alkaloid doses linked to adverse effects.", "population_specificity": "Not specified (literature review encompassing in vitro, in vivo, epidemiological, and human case data).", "effective_dosage": "Not specified (dose-dependent effects noted but no exact dosages provided).", "study_duration": "Not specified (review of existing studies with varying durations).", "interactions": "Activity on cytochrome P450 isoforms and opioid receptors noted, raising concerns for polysubstance users.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:51.068627+00:00"}
{"study_id": 22452, "supplement_id": 1261, "safety_score": "50", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review kratom's history, pharmacology, and early research on its potential as a harm reduction agent for substance use disorders, while addressing concerns and gaps in the literature.", "results_summary": "The abstract suggests kratom has potential as a harm reduction tool for opioid, alcohol, stimulant, and polysubstance use disorders, but highlights concerns about adverse effects, dependence risk, and regulatory issues. Early preclinical and observational studies support its therapeutic potential, though more research is needed.", "population_specificity": "Not specified (general substance use disorder population).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:53.822789+00:00"}
{"study_id": 22448, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to apply DSM-5 criteria for substance use disorders (SUDs) to kratom use and explore similarities/differences between kratom use disorder (KUD) and other SUDs, while proposing diagnostic and therapeutic recommendations.", "results_summary": "The study found that individuals meeting DSM-5 KUD criteria typically exhibit tolerance, withdrawal, overuse, and craving, but rarely functional or psychosocial disruption. Most clinicians treating isolated KUD use buprenorphine, though its safety and efficacy for KUD lack controlled studies.", "population_specificity": "Individuals with reported kratom use or suspected kratom use disorder (KUD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:55.228128+00:00"}
{"study_id": 22454, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to characterize kratom use behaviors, attitudes, and knowledge in a rural, underserved population.", "results_summary": "Active kratom use was uncommon (1 in 10 surveyed), with pain and mental health cited as primary reasons for use. Knowledge of kratom was low regardless of prior use.", "population_specificity": "Rural, underserved patients in Oregon (mostly female, white, and low-income).", "effective_dosage": "Not available", "study_duration": "Survey administered between January and April 2023 (cross-sectional).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:55.284965+00:00"}
{"study_id": 22453, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to examine kratom withdrawal in a medically complex patient and assess the effectiveness of buprenorphine-naloxone for managing withdrawal symptoms.", "results_summary": "The study found that kratom withdrawal contributed to a complex medical presentation and that buprenorphine-naloxone (8 mg/2 mg daily) reduced cravings and improved withdrawal symptoms. It also highlighted potential kratom-drug interactions due to its inhibitory effects on cytochrome P450 enzymes and P-glycoprotein.", "population_specificity": "72-year-old man admitted for deep vein thrombosis and obstructive uropathy experiencing kratom withdrawal.", "effective_dosage": "Buprenorphine-naloxone 8 mg/2 mg daily (kratom dosage not specified).", "study_duration": "Not specified.", "interactions": "Potential inhibitory effects on cytochrome P450 enzymes and P-glycoprotein.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:55.566693+00:00"}
{"study_id": 22455, "supplement_id": 1261, "safety_score": "20", "efficacy_score": 50, "quality_score": 30, "study_goal": "The researchers aimed to document a case of severe kratom use disorder and evaluate treatment outcomes using buprenorphine and naltrexone.", "results_summary": "The study found that a patient developed severe kratom use disorder, which was successfully treated with sublingual buprenorphine after failed trials of naltrexone. The case highlights uncertainties in diagnosing and treating kratom use disorder.", "population_specificity": "36-year-old male with no history of psychiatric disease, chronic pain, or substance use disorder.", "effective_dosage": "Not specified", "study_duration": "3 years of intermittent withdrawal management", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:56.084361+00:00"}
{"study_id": 22457, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the neuropharmacological effects of mitragynine (Kratom's main alkaloid) compared to morphine withdrawal in rats and explore potential treatments for cognitive deficits caused by withdrawal.", "results_summary": "Mitragynine withdrawal induced dose-dependent behavioral and cognitive impairments, reduced hippocampal synaptic plasticity, and altered epigenetic markers. The HDAC inhibitor SAHA reversed these effects for mitragynine but worsened morphine withdrawal symptoms.", "population_specificity": "Rats", "effective_dosage": "Mitragynine (1-10 mg\u00b7kg-1\u00b7day-1), morphine (5 mg\u00b7kg-1\u00b7day-1)", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:58.577455+00:00"}
{"study_id": 22458, "supplement_id": 1261, "safety_score": "20", "efficacy_score": 50, "quality_score": 30, "study_goal": "The researchers aimed to report a case of severe liver failure due to Kratom toxicity and evaluate the effectiveness of plasma exchange as an unconventional treatment.", "results_summary": "The study found that Kratom overdose led to severe jaundice and liver failure in a patient, with no liver mass detected. Plasma exchange significantly reduced bilirubin levels and improved the patient's condition, marking the first reported successful use of this treatment for Kratom poisoning.", "population_specificity": "A 56-year-old male with severe jaundice and liver failure.", "effective_dosage": "Not specified", "study_duration": "5 days (including four plasma exchange procedures)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:58.900324+00:00"}
{"study_id": 22456, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Kratom extracts (crude and alkaloid) could enhance the sensitivity of A549 human lung cancer cells to doxorubicin, potentially reducing the required dosage of the chemotherapy drug.", "results_summary": "The alkaloid extract (40-45% mitragynine) moderately inhibited A549 cancer cells via apoptosis, while the crude extract (4-5% mitragynine) showed no direct inhibition but enhanced doxorubicin sensitivity by 1.3-2.4 times. The alkaloid extract increased doxorubicin sensitivity by 2.6-3.4 times, demonstrating synergistic effects.", "population_specificity": "A549 human lung cancer cell lines", "effective_dosage": "Crude extract (10-60 ppm), alkaloid extract (10-60 ppm), doxorubicin (0.1 ppm)", "study_duration": "Not specified", "interactions": "Synergistic interaction with doxorubicin noted", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:17:59.857393+00:00"}
{"study_id": 22459, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the prevalence of kratom use, motives for use, and clinical associations among inpatients with severe psychiatric disorders.", "results_summary": "The study found that 2.2% of patients used kratom, primarily for managing opioid cravings, sobriety, low moods, and focus. Postsecondary education showed a fair to good association with kratom use (AUC = 0.77).", "population_specificity": "Inpatients aged 18-65 with severe psychiatric disorders, evaluated by New Hampshire Hospital's Addiction Services.", "effective_dosage": "Not available", "study_duration": "Data collected from January 1, 2020, to February 28, 2022 (no specific intervention duration mentioned).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:02.021349+00:00"}
{"study_id": 22460, "supplement_id": 1261, "safety_score": "40", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to understand whether and how individuals use kratom to self-treat stimulant use disorder.", "results_summary": "The study found that kratom was used to discontinue stimulants, with varying motivations and methods. While some reported benefits, others noted negative outcomes, including addiction and dependence.", "population_specificity": "Individuals discussing kratom use for stimulant discontinuation on social media.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:02.461138+00:00"}
{"study_id": 22461, "supplement_id": 1261, "safety_score": "50", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review basic facts about kratom and its potential pharmacological uses, including its major alkaloid mitragynine.", "results_summary": "The study highlights kratom's potential as a less toxic and less-addictive substitute for opium in pain relief, as well as its use for hypertension, cough, and diarrhea, but notes risks of addiction and negative social and health impacts.", "population_specificity": "Not specified (general review).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:03.294504+00:00"}
{"study_id": 22462, "supplement_id": 1261, "safety_score": "20", "efficacy_score": null, "quality_score": 60, "study_goal": "The researchers aimed to determine the risks of maternal Kratom use during pregnancy, particularly its association with Neonatal Abstinence Syndrome (NAS).", "results_summary": "The study found that maternal Kratom use during pregnancy led to severe NAS in a neonate, confirmed by the presence of mitragynine in the neonate's serum. NAS was successfully treated with oral phenobarbital.", "population_specificity": "Term neonate and mother using Kratom during pregnancy.", "effective_dosage": "Daily ingestion by the mother (exact amount not specified).", "study_duration": "Duration of maternal Kratom use during pregnancy (exact length not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:04.649998+00:00"}
{"study_id": 22463, "supplement_id": 1261, "safety_score": "75", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the in vitro inhibitory potential of kratom extracts and its major alkaloids on carboxylesterase 1 (CES1) to assess drug-drug interaction risks.", "results_summary": "Kratom extracts and major alkaloids showed concentration-dependent reversible inhibition of CES1, with varying Ki values. The study concluded that CES1-mediated drug-drug interactions are unlikely at typical doses (2-20g per dose), but further clinical studies are needed for higher or chronic use.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "2-20g per dose (mentioned as a spectrum of doses).", "study_duration": "Not specified.", "interactions": "Potential CES1 inhibition noted, but unlikely to cause significant drug-drug interactions at typical doses.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:05.560255+00:00"}
{"study_id": 22465, "supplement_id": 1261, "safety_score": "40", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the safety and toxicity profile of kratom decoction after 28 days of treatment in rats.", "results_summary": "The study found no mortality but observed toxicity in kidney and liver tissues, along with elevated liver enzymes and uric acid levels. No significant changes in body weight or hematology were noted, except for low platelet count.", "population_specificity": "Male and female Sprague Dawley rats", "effective_dosage": "10, 50, or 150 mg/kg (oral administration)", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:09.835877+00:00"}
{"study_id": 22464, "supplement_id": 1261, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to report a case of kratom overdose and highlight its potential risks and treatment in emergency settings.", "results_summary": "The study describes a case of hypoxia in a woman after consuming a large amount of kratom, reversed by naloxone, suggesting possible opioid-like toxicity. The patient survived due to prompt emergency care, emphasizing the need for awareness of kratom overdose in clinical practice.", "population_specificity": "A female in her 40s who consumed kratom.", "effective_dosage": "Large amount (unspecified exact dosage).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:09.887957+00:00"}
{"study_id": 22467, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to summarize existing literature on kratom's use for chronic pain and explore potential therapeutic benefits of co-administration with cannabinoids.", "results_summary": "Epidemiological evidence suggests kratom is used for self-treatment of pain, but there is limited pre-clinical research on its efficacy compared to cannabis. Some individuals use both substances concurrently, possibly for additive effects.", "population_specificity": "Adult Americans using kratom or cannabis for chronic pain.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:11.253569+00:00"}
{"study_id": 22468, "supplement_id": 1261, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to highlight the risks of naltrexone-precipitated withdrawal in a patient with undisclosed chronic kratom use.", "results_summary": "The study found that kratom use can lead to serious withdrawal symptoms when naltrexone is administered, emphasizing the need for thorough assessment of herbal supplements due to potential medication interactions.", "population_specificity": "A patient with chronic kratom use (specific demographics not provided).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "Naltrexone (precipitated withdrawal)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:11.685317+00:00"}
{"study_id": 22471, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to compare the prevalence of past-12-month kratom use across different state legal frameworks (no policy, KCPAs, bans) and assess associations with opioid use disorder treatment.", "results_summary": "The study found lower estimated prevalence of kratom use in banned states compared to states with KCPAs or no policies, though policy type was not significantly associated with odds of use. Kratom use was significantly linked to medicated treatment for opioid use disorder.", "population_specificity": "Nationally-representative survey participants in the U.S.", "effective_dosage": "Not available", "study_duration": "Not applicable (cross-sectional survey)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:12.488062+00:00"}
{"study_id": 22466, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to assess the feasibility of telehealth and unobserved buprenorphine-naloxone home induction for managing kratom use disorder.", "results_summary": "Two patients with kratom use disorder successfully underwent unobserved home induction with buprenorphine-naloxone via telehealth, stabilizing on different dosages without adverse effects. The study suggests this method may be an alternative where traditional treatment access is limited.", "population_specificity": "Two patients with kratom use disorder consuming 35 g/day.", "effective_dosage": "35 g of kratom per day (prior to induction); buprenorphine-naloxone dosage varied post-induction.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:12.815133+00:00"}
{"study_id": 22472, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review literature on kratom use as a substitute for other drugs or as a nonmedical self-treatment for substance use disorder (SUD) symptoms.", "results_summary": "Kratom has been used as an opioid substitute, but evidence for reducing alcohol or stimulant use is limited. Data primarily come from self-reports, leaving abuse liability and therapeutic potential unclear.", "population_specificity": "Individuals with polydrug use histories, including those using kratom as a substitute or for SUD self-management.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:12.826315+00:00"}
{"study_id": 22474, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antidiabetic and antihyperlipidemic effects of Kratom ethanolic extract in fructose/STZ-induced type 2 diabetic rats.", "results_summary": "Kratom extract demonstrated significant antioxidant and \u03b1-glucosidase inhibitory activity, improved blood glucose levels, lipid profiles, hepatorenal biomarkers, and oxidative stress indices, and restored pancreatic histology in diabetic rats.", "population_specificity": "Fructose/STZ-induced type 2 diabetic rats", "effective_dosage": "100 and 400 mg/kg, administered via oral gavage", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:17.047811+00:00"}
{"study_id": 22475, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 87, "quality_score": 85, "study_goal": "The researchers aimed to determine which form of Kratom extracts (syrup, alkaloids, aqueous) exhibits antidepressant effects most similar to fluoxetine by analyzing mice's local field potential responses.", "results_summary": "Kratom syrup showed the highest similarity (87.11%) to fluoxetine in antidepressant effects compared to other Kratom forms. The study also achieved high accuracy (90.11%) and F1-score (90.08%) in classifying LFP responses to different Kratom extracts and fluoxetine.", "population_specificity": "Mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:18.753132+00:00"}
{"study_id": 22476, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether mitragynine (MG) exposure could trigger opioid-seeking behavior in rats following abstinence, assessing its potential as a treatment for opioid dependence.", "results_summary": "The study found that a low dose of MG (10 mg/kg) reinstated morphine-seeking behavior, while a higher dose (30 mg/kg) suppressed it, suggesting MG may increase relapse risk at lower doses.", "population_specificity": "Male Sprague-Dawley rats trained to self-administer morphine.", "effective_dosage": "3, 10, and 30 mg/kg MG (intraperitoneal injections).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:19.546078+00:00"}
{"study_id": 22477, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 30, "study_goal": "The researchers aimed to explore the challenges and successes of using buprenorphine for post-operative pain management in a patient taking kratom for chronic pain and opioid withdrawal.", "results_summary": "The study reported mixed outcomes with buprenorphine for post-operative pain in a kratom-using patient, highlighting both challenges and successes. It adds to evidence supporting buprenorphine for kratom withdrawal and perioperative pain management.", "population_specificity": "A patient with a history of opioid use disorder and chronic pain using kratom, undergoing elective total knee replacement.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:20.404110+00:00"}
{"study_id": 22479, "supplement_id": 1261, "safety_score": "20", "efficacy_score": 30, "quality_score": 25, "study_goal": "The researchers aimed to highlight the risks and potential addiction associated with kratom use, particularly in individuals with a history of opioid use disorder and major depressive disorder.", "results_summary": "The study found that kratom use led to addiction in a patient with a history of opioid use disorder, resulting in withdrawal symptoms and an eventual overdose on depression medications. The patient required psychiatric hospitalization and treatment with Suboxone to manage withdrawal.", "population_specificity": "A 38-year-old woman with a history of major depressive disorder and opioid use disorder.", "effective_dosage": "Large quantities per day (exact amount not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:20.854816+00:00"}
{"study_id": 22480, "supplement_id": 1261, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to investigate a case of acute liver injury linked to kratom use in a patient with post-COVID syndrome.", "results_summary": "The study reported a case of mixed cholestatic-hepatocellular liver injury in a young man who consumed kratom recreationally for post-COVID insomnia. Liver function tests showed significant abnormalities, but the patient recovered after discontinuing kratom and receiving conservative treatment.", "population_specificity": "A 23-year-old Thai man with a history of mild COVID-19 pneumonia.", "effective_dosage": "Not specified (used in a homemade iced cocktail called \"4 \u00d7 100\").", "study_duration": "2 weeks.", "interactions": "Diphenhydramine-containing cough syrup.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:21.079136+00:00"}
{"study_id": 22478, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to assess kratom use patterns and self-reported effects on psychiatric conditions (ADHD, PTSD, depressive and anxiety disorders) among users.", "results_summary": "Users reported decreased depressive and anxious moods after kratom use, with higher concurrent or prior use of cannabis, CBD, and benzodiazepines. The study suggests observational and clinical follow-up is warranted.", "population_specificity": "Middle-aged (31-50 years), employed, college-educated individuals who use kratom.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "Concurrent use with cannabis, cannabidiol, and benzodiazepines noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:21.796212+00:00"}
{"study_id": 22470, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the potential involvement of cannabinoid mechanisms in the efficacy of mitragynine (MG) in a rodent model of chemotherapy-induced peripheral neuropathy (CIPN).", "results_summary": "The study found that MG's efficacy in alleviating oxaliplatin-induced mechanical hypersensitivity was partially dependent on cannabinoid receptors and fully blocked by pharmacological inhibition of CB1, CB2, and TRPV1 channels. MG also prevented oxaliplatin-induced disruptions in the spinal cord endocannabinoid lipidome.", "population_specificity": "Wildtype and cannabinoid receptor knockout mice.", "effective_dosage": "Not specified (intraperitoneal administration).", "study_duration": "Not specified.", "interactions": "Co-administration with cannabinoids may increase therapeutic efficacy.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:22.777297+00:00"}
{"study_id": 22481, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of kratom extracts and mitragynine on \u03b1-glucosidase and pancreatic lipase activities, as well as their potential for diabetes treatment and prevention.", "results_summary": "The ethanol extract of kratom showed the highest inhibition activity against \u03b1-glucosidase and pancreatic lipase, with mitragynine demonstrating potent \u03b1-glucosidase inhibition and synergistic effects when combined with acarbose.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic interaction with acarbose noted for \u03b1-glucosidase inhibition", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:24.943541+00:00"}
{"study_id": 22482, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify patterns of polysubstance use (PSU) among US adults who reported past 12-month use of kratom and at least one additional substance.", "results_summary": "The study identified three distinct PSU profiles among kratom users: \"marijuana/alcohol/tobacco\" (63.3%), \"marijuana/alcohol/tobacco + psychedelics\" (19.3%), and \"marijuana/alcohol/tobacco + psychedelics/heroin/prescriptions\" (17.4%). This suggests kratom use is often associated with other substance use, but the study did not assess kratom's direct effects.", "population_specificity": "412 US adults reporting past 12-month use of kratom and at least one of 11 additional substances.", "effective_dosage": "Not available", "study_duration": "Not applicable (observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:30.062594+00:00"}
{"study_id": 22483, "supplement_id": 1261, "safety_score": "40", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to analyze calls to the British Columbia poison centre to describe kratom exposures and their acute health effects.", "results_summary": "The study found a steady increase in kratom-related poison centre calls from 2012 to 2019, primarily among young adult males, with ingestion being the most common exposure route. No deaths were reported, but one case required intubation due to agitation from kratom withdrawal.", "population_specificity": "Callers to the British Columbia poison centre, predominantly males in their 20s.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Concurrent drug exposure noted in 41% of cases.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:30.113903+00:00"}
{"study_id": 22485, "supplement_id": 1261, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to highlight potential adverse effects of kratom, particularly its association with renal insufficiency and adulteration risks.", "results_summary": "The study reported a case of renal insufficiency linked to adulterated kratom containing hydrocodone and morphine, with symptoms resolving after discontinuation. It underscores the risks of unregulated kratom products.", "population_specificity": "A 21-year-old African-American woman with a history of occasional headaches.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:31.060808+00:00"}
{"study_id": 22484, "supplement_id": 1261, "safety_score": "75", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to assess public perceptions of kratom use, focusing on motives for use, abuse potential, and medical usefulness to inform regulatory decisions.", "results_summary": "Respondents reported diverse health-related reasons for kratom use, primarily for mental health, pain management, and substance use disorder, with minimal reports of recreational use or adverse effects. The study highlights public perceptions of kratom's therapeutic potential but lacks independent verification of claims.", "population_specificity": "Public respondents to an FDA solicitation for comments on kratom (6,353 comments analyzed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:31.167406+00:00"}
{"study_id": 22486, "supplement_id": 1261, "safety_score": "30", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to assess the public health implications of lead contamination in kratom products and its potential toxic effects on users.", "results_summary": "The study found that many kratom products in the U.S. contain hazardous levels of lead (Pb), posing potential health risks. It also discussed how lead toxicity might interact with kratom's known physiological effects.", "population_specificity": "Kratom users in the United States.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:31.560664+00:00"}
{"study_id": 22487, "supplement_id": 1261, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to investigate the potential risk of serotonin syndrome induced by kratom when used in combination with prescription psychotropic medications.", "results_summary": "The study reported a case of serotonin syndrome in a patient using kratom alongside multiple serotonergic medications, suggesting that kratom may inhibit cytochrome P450 enzymes, increasing systemic serotonin levels. Symptoms improved after treatment with cyproheptadine, supporting the hypothesis of a pharmacokinetic interaction.", "population_specificity": "63-year-old male with chronic anxiety/depression on multiple psychotropic medications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Kratom interacts with cytochrome P450 isozymes (3A4, 2C9, 2D6, 1A2), potentially inhibiting metabolism of serotonergic medications like bupropion, buspirone, desvenlafaxine, trazodone, and ziprasidone.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:35.570873+00:00"}
{"study_id": 22489, "supplement_id": 1261, "safety_score": "40", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the current understanding of kratom's effects, safety profile, and potential therapeutic uses, as well as identify gaps in knowledge requiring further clinical investigation.", "results_summary": "The study found that kratom has dose-dependent stimulant and opioid-like effects, with reported uses including self-treatment of mood disorders, pain, and substance use disorders. Adverse effects, primarily hepatic, cardiac, and CNS-related, were noted, often in polydrug exposure cases, but clinical significance remains unclear due to limited controlled trials.", "population_specificity": "Not specified (general discussion of kratom use in the US and Europe).", "effective_dosage": "Not specified (mentions variability in commercial product composition).", "study_duration": "Not specified.", "interactions": "CYP 3A4 and 2D6 inhibition (clinical significance unknown).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:35.682910+00:00"}
{"study_id": 22490, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to critique inconsistencies and lack of context in a case report on kratom use disorder and buprenorphine/naloxone induction.", "results_summary": "The study identified inconsistencies and generalizations in the case report, noting these issues are common in kratom-related literature, and sought to highlight them to improve future research and clinical understanding.", "population_specificity": "28 patients in the United States who identified kratom as their primary substance of use.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:37.327502+00:00"}
{"study_id": 22493, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 50, "quality_score": 40, "study_goal": "The researchers aimed to examine the problematic use of kratom and its treatment in a patient with social phobia, highlighting the need for addiction anamnesis and interdisciplinary cooperation.", "results_summary": "The study found that kratom use led to opioid-like withdrawal symptoms, requiring outpatient detoxification. Treatment involved collaboration between psychiatric and psychotherapeutic practices, with abstinence and social phobia management as ongoing goals.", "population_specificity": "A single patient with social phobia and problematic kratom use.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:38.610479+00:00"}
{"study_id": 22491, "supplement_id": 1261, "safety_score": "45", "efficacy_score": null, "quality_score": 60, "study_goal": "The researchers aimed to review health effects associated with kratom use, either alone or with other substances, to inform medical awareness and clinical decision-making.", "results_summary": "The study noted cardiovascular, gastrointestinal, neurological, and psychiatric effects linked to kratom use, as well as concerns about neonatal abstinence syndrome. It highlighted challenges in assessing kratom-related fatalities due to lack of routine toxicology screening and potential confounding by polysubstance use.", "population_specificity": "General kratom users, including cases of polysubstance use and neonates exposed in-utero.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Polysubstance use, adulteration of kratom products, and drug-herb interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:38.958160+00:00"}
{"study_id": 22494, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 40, "quality_score": 50, "study_goal": "The researchers aimed to explore the correlation between kratom misuse and stimulant use disorders, highlighting clinical neglect of this overlap.", "results_summary": "The study presents three cases demonstrating the overlap between kratom misuse and stimulant use disorders, noting kratom's increasing use in the U.S. and its risks analogous to opioids.", "population_specificity": "Individuals with kratom misuse and potential stimulant use disorders (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:39.024436+00:00"}
{"study_id": 22492, "supplement_id": 1261, "safety_score": "45", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the pharmacological properties, uses, safety, and public health implications of kratom, particularly comparing its effects in Western countries versus Southeast Asia.", "results_summary": "Kratom contains alkaloids like mitragynine and 7-hydroxymitragynine, which act on opioid receptors with potential analgesic and stimulant effects, but its safety profile is complicated by reports of hepatotoxicity, cardiotoxicity, and polysubstance-related adverse events in Western countries. While its addictive potential appears lower than classical opioids, kratom use disorders and severe health problems have been reported, particularly in the US.", "population_specificity": "General users in Western countries (primarily the US and Europe) and Southeast Asia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Inhibits CYP26, CYP2C19, and CYP3A4 enzymes, potentially affecting drug metabolism.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:40.625547+00:00"}
{"study_id": 22495, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to highlight anesthetic challenges posed by heavy kratom use in patients undergoing anesthesia.", "results_summary": "The abstract notes that kratom is used for anxiety, pain, and opioid withdrawal but does not provide specific study results on efficacy or safety. It mentions anesthetic challenges in a heavy kratom user.", "population_specificity": "Heavy kratom user undergoing anesthesia.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:42.172160+00:00"}
{"study_id": 22497, "supplement_id": 1261, "safety_score": "40", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to review the safety and potential medical applications of kratom, focusing on its opioid and stimulant properties.", "results_summary": "The study found that kratom has both beneficial effects (e.g., potential for treating alcohol/opioid use disorders, pain, depression, anxiety) and adverse effects (e.g., addiction, withdrawal). However, the lack of controlled studies limits its clinical utility and safety.", "population_specificity": "Humans and animals (based on literature review, no specific population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:44.775385+00:00"}
{"study_id": 22496, "supplement_id": 1261, "safety_score": "65", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to understand kratom's role in perceived well-being, self-treatment of substance use disorders (SUDs), and its correlation with drug use.", "results_summary": "Kratom was primarily used for self-treating pain (73.0%) and improving mental health (42.2%), with dose-dependent benefits for pain and mood relief. Adverse effects were mainly gastrointestinal at high or frequent doses.", "population_specificity": "5,152 people who use kratom (PWUK), recruited via social media and online resources (45.9% female, 53.7% male).", "effective_dosage": "Adverse effects noted at >5 g/dose and >22 doses/week.", "study_duration": "Survey conducted between July 2019 and July 2020 (no specific intervention duration).", "interactions": "Primary substances taken concomitantly were cannabis, cannabidiol, benzodiazepines, or kava.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:45.422521+00:00"}
{"study_id": 22488, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess current trends in kratom use, including initiation, sourcing, motivations, preferences, and perceived stigma among current and former users.", "results_summary": "The study found that kratom use motivations are diversifying, with many users endorsing self-treatment purposes such as substituting opioids, alcohol, or stimulants. Kratom was ranked as a preferred substance by 48.5% of respondents, and its use was strongly associated with past-month cannabis use and vaped nicotine.", "population_specificity": "129 current and former kratom users, majority female (51.9%) and white (71.9%), with most first trying kratom after 2015.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Use was less likely among those prescribed buprenorphine in the past year.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:45.701123+00:00"}
{"study_id": 22500, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to understand if and how COVID-19 influenced kratom purchasing and use patterns.", "results_summary": "The study found no significant changes in kratom use patterns during COVID-19, though concerns about product shortages and quality issues were prevalent. Social media discussions highlighted themes of quitting kratom, misinformation, and rationing due to perceived dependence.", "population_specificity": "Primarily non-Hispanic whites (87.1%), with a relatively small sample size (n=70) of younger consumers.", "effective_dosage": "Not specified", "study_duration": "Data collected between January and July 2020 (6 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:46.886890+00:00"}
{"study_id": 22498, "supplement_id": 1261, "safety_score": "45", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to assess kratom use disorder (KUD) and withdrawal symptoms among regular kratom users, as well as identify clinical characteristics of those with current, remitted, or no KUD.", "results_summary": "The study found that 29.5% of respondents met criteria for current KUD, with withdrawal symptoms including gastrointestinal upset, restlessness, and anxiety. Kratom was often used for pain, psychiatric symptoms, and polydrug use, but tolerance and withdrawal were primary KUD features rather than psychosocial impairments.", "population_specificity": "Current and former kratom users in the United States, recruited from an online survey.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:47.254616+00:00"}
{"study_id": 22499, "supplement_id": 1261, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to provide an updated abuse potential assessment of kratom alkaloids (mitragynine and 7-hydroxymitragynine) and evaluate public health risks associated with CSA scheduling.", "results_summary": "The study found that kratom's abuse potential is comparable to other uncontrolled substances, with no imminent public health risk, and that scheduling it could lead to adverse outcomes like increased opioid overdoses. Continued access to kratom is recommended to support consumer use and research, while regulation is advised to minimize risks from contaminated or adulterated products.", "population_specificity": "Long-term kratom users, animal models, and in-vitro studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:47.647496+00:00"}
{"study_id": 22501, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 50, "quality_score": 40, "study_goal": "The researchers aimed to investigate potential pharmacokinetic drug interactions involving kratom and its association with serotonin syndrome and electrocardiogram abnormalities.", "results_summary": "The study reported a case where high daily kratom use (~90 g) may have contributed to serotonin syndrome and corrected electrocardiogram abnormalities in a patient taking venlafaxine and quetiapine. Symptoms resolved after discontinuation of the medications, and buprenorphine/naloxone facilitated recovery from kratom use disorder.", "population_specificity": "A single patient with opioid use disorder taking venlafaxine and quetiapine.", "effective_dosage": "~90 g daily", "study_duration": "Not specified", "interactions": "Potential interactions with venlafaxine (CYP2D6/3A substrate) and quetiapine (CYP3A substrate).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:50.732487+00:00"}
{"study_id": 22502, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of buprenorphine/naloxone as a treatment for kratom use disorder (KUD).", "results_summary": "The study found that buprenorphine/naloxone was effective for treating KUD, with 68-82% of patients testing negative for mitragynine at 4-12 weeks. Most patients remained in treatment for an average of 11 months, though some were lost to follow-up.", "population_specificity": "28 patients self-identifying kratom as their primary substance of use, with usage durations ranging from 1 month to 25 years.", "effective_dosage": "Average daily kratom dose was 92 g/d; buprenorphine/naloxone doses ranged from 1-20 mg.", "study_duration": "Treatment duration ranged from 5 to 22 months, averaging 11 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:52.855281+00:00"}
{"study_id": 22503, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lifetime and past-year kratom use were associated with region of residence and specific demographic factors (age, race, education, employment).", "results_summary": "The study found that kratom use was higher among White, younger, employed, and educated individuals, as well as those with a history of nonmedical opioid use or substance use disorder. Residence was not a significant predictor, but suburban residence in NSDUH data aligned with demographic trends.", "population_specificity": "US adults, particularly White, younger, employed, and educated individuals, with a focus on those reporting nonmedical opioid use or substance use disorder.", "effective_dosage": "Not available", "study_duration": "Not applicable (survey-based study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:54.959242+00:00"}
{"study_id": 22504, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess characteristics associated with lifetime methamphetamine and/or kratom use among individuals with a history of non-medical opioid use.", "results_summary": "The study found that individuals who used kratom alongside non-medical opioids were more likely to report serious mental illness, suicidality, and psychological distress. The group using kratom, methamphetamine, and non-medical opioids showed the highest risk factors, including unmet mental health needs and increased odds for drug injection and opioid withdrawal.", "population_specificity": "Nationally representative US sample of individuals with lifetime non-medical opioid use (diverted prescription opioids, heroin).", "effective_dosage": "Not available", "study_duration": "Not applicable (lifetime use assessment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:55.456743+00:00"}
{"study_id": 22505, "supplement_id": 1261, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if kratom alkaloids like paynantheine and speciogynine, with reduced \u00b5OR potency, could serve as safer alternatives for treating alcohol use disorder by enhancing \u03b4OR activity.", "results_summary": "Paynantheine showed aversion in limited CPP tests but did not produce robust antinociception or counteract morphine CPP. 7-hydroxyspeciogynine reduced alcohol consumption in WT mice without significant CPP, hyperlocomotion, or seizures at tolerated doses.", "population_specificity": "Male C57BL/6N WT and \u03b4OR knockout mice", "effective_dosage": "10\u201330 mg\u2219kg-1 (i.p. or s.c.)", "study_duration": "Not specified", "interactions": "Blocked morphine-induced antinociception and hyperlocomotion", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:55.876748+00:00"}
{"study_id": 22507, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers aimed to examine the psychosocial factors and substance-use patterns associated with kratom use among U.S. adults with recent alcohol, opioid, or stimulant use.", "results_summary": "The study found that kratom users were more likely to have chronic pain, mental health issues, and higher rates of substance use, including nonmedical prescription opioids and diverted opioid agonist therapy medications. Kratom use was strongly predicted by the use of other substances like cannabidiol, psychedelics, and nonmedical prescription opioids.", "population_specificity": "U.S. adults with past 6-month alcohol, opioid, or stimulant use (N = 1,510 evaluable respondents).", "effective_dosage": "Not available", "study_duration": "Not applicable (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:56.699842+00:00"}
{"study_id": 22508, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of CB1 receptors in cognitive deficits caused by chronic mitragynine (Kratom's major psychoactive constituent) exposure in mice.", "results_summary": "Chronic high-dose mitragynine (5-25 mg/kg) induced hyperlocomotion, increased reward preference, resistance to punishment, and impaired learning, similar to THC and morphine. These deficits were reversed by CB1 receptor antagonism, suggesting CB1 receptors mediate these effects.", "population_specificity": "Adult male Swiss albino mice", "effective_dosage": "1-25 mg/kg (incremental dose sensitization over 28 days)", "study_duration": "28 days", "interactions": "CB1 receptor antagonist (NIDA-41020) reversed deficits induced by mitragynine, THC, and morphine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:57.258998+00:00"}
{"study_id": 22509, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to highlight the increasing interest in kratom as a potential harm reduction agent for pain and opioid use disorder in the context of restricted opioid access and the COVID-19 pandemic.", "results_summary": "The abstract reports that kratom has been traditionally used for fatigue, mood improvement, pain relief, and opioid withdrawal management, with recent interest in the U.S. for similar purposes. It suggests kratom may serve as a harm reduction tool amid the opioid crisis.", "population_specificity": "Native populations in Southeast Asia and recent users in the United States, particularly those with chronic pain or opioid use disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:59.058199+00:00"}
{"study_id": 22511, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of mitragynine on dopamine levels and dopamine transporter expression in the frontal cortex of rats to understand its potential for addiction.", "results_summary": "Mitragynine did not increase dopamine release after acute treatment but significantly and dose-dependently increased dopamine release after repeated exposure (4 days). It also increased DAT mRNA expression at the highest dose (30 mg/kg).", "population_specificity": "Rats", "effective_dosage": "1 and 30 mg/kg", "study_duration": "4 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:01.643332+00:00"}
{"study_id": 22510, "supplement_id": 1261, "safety_score": "20", "efficacy_score": null, "quality_score": 40, "study_goal": "The researchers aimed to document severe adverse effects of kratom misuse, including rare complications like rhabdomyolysis and renal failure.", "results_summary": "The study found that kratom misuse led to severe toxic effects, including cerebrovascular accident, rhabdomyolysis, renal failure, and nonischemic cardiomyopathy, with long-term consequences like hemodialysis dependence. Some effects were reversible with medical intervention, while others caused permanent damage.", "population_specificity": "A single patient admitted to the intensive care unit after kratom abuse.", "effective_dosage": "Abusive doses (specific amount not stated).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:01.702161+00:00"}
{"study_id": 22512, "supplement_id": 1261, "safety_score": "30", "efficacy_score": null, "quality_score": 60, "study_goal": "The researchers aimed to review the epidemiology and pharmacology of kratom and provide guidance for primary care physicians on identifying and treating kratom use disorder.", "results_summary": "The abstract highlights the increasing prevalence of kratom use, its potential lethality, and the need for physician awareness and intervention frameworks for kratom use disorder.", "population_specificity": "General population, with a focus on individuals with kratom use disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:03.089868+00:00"}
{"study_id": 22513, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the potential of M. speciosa alkaloids (mitragynine, speciociliatine, paynantheine) as chemosensitizers for cisplatin in Nasopharyngeal carcinoma (NPC) cell lines.", "results_summary": "Mitragynine and speciociliatine sensitized NPC cell lines to cisplatin, enhancing its effect by ~4- and >5-fold, respectively, and significantly inhibited cell migration and spheroid invasion. The combination did not rapidly induce resistance over 10 days.", "population_specificity": "Nasopharyngeal carcinoma (NPC) cell lines (NPC/HK1 and C666-1).", "effective_dosage": "Not specified", "study_duration": "10 days (for spheroid resistance assessment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:04.692115+00:00"}
{"study_id": 22515, "supplement_id": 1261, "safety_score": "60", "efficacy_score": 70, "quality_score": 40, "study_goal": "The researchers aimed to evaluate the effectiveness and limitations of Kratom as a self-management tool for depression and anxiety, particularly under increased psychological stress.", "results_summary": "Kratom was initially effective in managing depression and Meni\u00e8re's symptoms without dose escalation, but its efficacy diminished under heightened stress during the COVID-19 pandemic, leading to treatment failure and subsequent detoxification.", "population_specificity": "A 63-year-old man with long-term major depression, generalized anxiety disorder, and a history of alcohol addiction.", "effective_dosage": "3-4 times daily (exact amount not specified)", "study_duration": "Approximately 7 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:04.806322+00:00"}
{"study_id": 22514, "supplement_id": 1261, "safety_score": "45", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to analyze social media posts to validate prior survey findings on kratom use patterns and gain a nuanced understanding of its effects, including self-treatment for opioid withdrawal and longer-term substitution.", "results_summary": "The study found that while kratom was associated with desirable effects, adverse effects and dose-dependent addiction risks were also prominent. Higher doses were linked to greater odds of addiction and withdrawal, with slightly lower odds of desirable effects.", "population_specificity": "Users discussing kratom on Reddit (42 subreddits, 1274 posts analyzed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Polydrug use was prominently discussed, but no specific interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:05.152225+00:00"}
{"study_id": 22516, "supplement_id": 1261, "safety_score": "30", "efficacy_score": null, "quality_score": 40, "study_goal": "The researchers aimed to highlight potential complications of kratom use, particularly liver injury and opioid withdrawal precipitated by naltrexone in kratom users.", "results_summary": "The study reported a case of kratom-induced liver inflammation complicated by opioid withdrawal following naltrexone administration, suggesting potential risks associated with kratom use and its interaction with medications.", "population_specificity": "Case report of an individual using kratom (specific demographics not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Potential additive liver toxicity with hepatotoxic medications (OTC, herbal, prescription).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:06.813966+00:00"}
{"study_id": 22518, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compile available information on managing \"kratom use disorder\" (KUD) and develop a consensus on pharmacological treatment standards.", "results_summary": "The study found that buprenorphine, naltrexone, and methadone were effective in managing KUD, with favorable outcomes. Expert consensus supported extending medication-assisted treatment for opioid use disorder (MOUD) to moderate-to-severe KUD cases.", "population_specificity": "Individuals with kratom use disorder (KUD), including those without comorbid opioid use disorder (OUD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:10.074712+00:00"}
{"study_id": 22517, "supplement_id": 1261, "safety_score": "20", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to report a case of severe rhabdomyolysis and pressure necrosis linked to Kratom use, highlighting its potential adverse effects.", "results_summary": "The study found that Kratom use led to severe rhabdomyolysis, acute renal and hepatic injury, and compartment syndrome requiring fasciotomy in a patient. It underscores Kratom's profound sedative effects and associated risks.", "population_specificity": "A 31-year-old male with substance use history.", "effective_dosage": "Not specified (smoked Kratom, but exact dosage not provided).", "study_duration": "Single acute exposure (6-hour loss of consciousness).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:10.334191+00:00"}
{"study_id": 22519, "supplement_id": 1261, "safety_score": "40", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to describe the neurochemical mechanisms of Kratom and its effects, including potential adverse outcomes and withdrawal symptoms.", "results_summary": "Kratom exhibits complex neurochemical interactions, producing stimulant effects at low doses and sedative-analgesic effects at higher doses, but no clear dosage threshold was identified. Long-term use may lead to withdrawal-like symptoms, including anxiety, mood disorders, and insomnia, as illustrated in a case study where symptoms persisted post-withdrawal.", "population_specificity": "Case study of a patient with anxiety, dysphoric mood, and insomnia after Kratom use.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:11.241488+00:00"}
{"study_id": 22522, "supplement_id": 1261, "safety_score": "20", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to review the effects of prenatal kratom exposure on maternal and infant outcomes.", "results_summary": "The study found that maternal and infant withdrawal from kratom exposure occurred in all six case reports, requiring pharmacologic treatment for both mothers and infants.", "population_specificity": "Pregnant women and their infants.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:11.248839+00:00"}
{"study_id": 22520, "supplement_id": 1261, "safety_score": "20", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to investigate the potential adverse effects of kratom, specifically its association with intracerebral hemorrhage.", "results_summary": "The study reported a case of intracerebral hemorrhage possibly linked to kratom ingestion, highlighting potential public health risks. Adverse reactions to kratom are largely unknown, but this case suggests significant safety concerns.", "population_specificity": "A single male patient with intracerebral hemorrhage.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:12.033248+00:00"}
{"study_id": 22521, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of buprenorphine/naloxone for treating kratom dependence and withdrawal in Veterans.", "results_summary": "The study found that buprenorphine/naloxone effectively treated kratom dependence, with induction possible as early as eight hours after last kratom use. Prolonged withdrawal symptoms were reported, and higher doses (up to 24mg/day) may be beneficial for managing withdrawal and co-occurring pain.", "population_specificity": "Veterans receiving care at the George E. Wahlen Department of Veterans Affairs Medical Center.", "effective_dosage": "Up to 24mg per day of buprenorphine/naloxone.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:14.071814+00:00"}
{"study_id": 22523, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the stability and metabolism of 7-hydroxymitragynine (7-HMG), a key alkaloid in kratom, in different species' plasma and its implications for kratom's pharmacology in humans.", "results_summary": "The study found that 7-HMG is stable in rodent and monkey plasma but unstable in human plasma, where it converts to mitragynine pseudoindoxyl, a more potent opioid. This novel metabolite may significantly influence kratom's effects in humans compared to other species.", "population_specificity": "In vitro study using plasma from humans, mice, rats, dogs, and cynomolgus monkeys.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:15.537925+00:00"}
{"study_id": 22524, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 30, "study_goal": "The researchers aimed to evaluate the effectiveness of kratom in alleviating COVID-19-related symptoms such as malaise, fatigue, pain, and headache.", "results_summary": "The study observed rapid and sustained relief of COVID-19 symptoms, including malaise, fatigue, pain, and headache, in a patient using kratom.", "population_specificity": "A single patient with confirmed COVID-19 infection.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:17.459775+00:00"}
{"study_id": 22525, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to highlight the increasing use of kratom outside Southeast Asia, its potential risks, and the implications of supply shortages during the COVID-19 pandemic.", "results_summary": "The abstract notes kratom's traditional use and its growing popularity for self-treatment of pain, psychiatric disorders, and opioid withdrawal, but warns of potential risks due to supply shortages and adulterated products.", "population_specificity": "Kratom users, particularly those in the US and Europe, including individuals self-treating pain, psychiatric disorders, or substance use disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:18.782781+00:00"}
{"study_id": 22526, "supplement_id": 1261, "safety_score": "20", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effectiveness of a contingency management program combined with buprenorphine for treating kratom use disorder.", "results_summary": "The study found that kratom use leads to physiological dependence and addiction similar to other opioids. The combination of contingency management and buprenorphine was effective in treating kratom use disorder in the two cases studied.", "population_specificity": "Two individuals with kratom use disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:19.832343+00:00"}
{"study_id": 22527, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 35, "study_goal": "The researchers sought to determine whether kratom use was associated with a reduction in HIV risk behaviors among out-of-treatment HIV-positive opiate users.", "results_summary": "More than one-third (38%) of participants reported that kratom use reduced their risky injecting and sexual behaviors, but the small sample size limited conclusive findings. Kratom was used to suppress opiate withdrawal, increase energy, as a heroin substitute, and self-treat psychological problems.", "population_specificity": "Thirty-two HIV-positive opiate users not in treatment.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:20.347544+00:00"}
{"study_id": 22528, "supplement_id": 1261, "safety_score": "50", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to profile commercial kratom products and evaluate the opioid receptor binding activity of key alkaloids (speciofoline, mitragynine, and 7-hydroxymitragynine) to assess their potential for pain management.", "results_summary": "The study identified two distinct kratom chemotypes with varying speciofoline levels, confirmed mitragynine and 7-hydroxymitragynine as partial \u00b5-opioid receptor agonists with G-protein signaling selectivity, and found no opioid receptor binding for speciofoline. The alkaloids also inhibited select cytochrome P450 enzymes, indicating potential drug interaction risks.", "population_specificity": "Not specified (in vitro and commercial product analysis).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Potential adverse interactions with drugs metabolized by cytochrome P450 enzymes.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:22.900195+00:00"}
{"study_id": 22529, "supplement_id": 1261, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate kratom tea's antinociceptive effects, potential for physical dependence, and its ability to ameliorate opioid withdrawal symptoms.", "results_summary": "Kratom tea produced dose-dependent antinociception mediated by mu-opioid receptors, did not cause physical dependence, and significantly reduced withdrawal symptoms in morphine-dependent mice. It did not impair locomotion or induce conditioned place preference and only briefly reduced respiration.", "population_specificity": "C57BL/6J and opioid receptor knockout mice", "effective_dosage": "\u22651 g/kg, orally", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:23.181610+00:00"}
{"study_id": 22530, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 50, "quality_score": 20, "study_goal": "The researchers aimed to document a case of Kratom withdrawal manifesting as obsessive thoughts and explore lorazepam's role in mitigating these symptoms.", "results_summary": "The study reported a case of disturbing obsessive thoughts following Kratom discontinuation after use as an opioid replacement. Lorazepam was used to alleviate these symptoms, marking the first documented instance of this treatment approach.", "population_specificity": "A single patient using Kratom as an opioid replacement.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:23.949182+00:00"}
{"study_id": 192343, "supplement_id": 1261, "safety_score": "50", "efficacy_score": 70, "quality_score": 60, "study_goal": "To compare traditional Southeast Asian use of kratom with its modern Western applications, focusing on safety, effects, and potential harms.", "results_summary": "Kratom has traditional uses for stamina, mood enhancement, pain, and opioid addiction, but Western misuse of highly concentrated products has led to harm. The effects vary from stimulant to sedative depending on dosage, with mitragynine being the most studied alkaloid for opioid-like effects.", "population_specificity": "Traditional Southeast Asian users and Western consumers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:29.289279+00:00"}
{"study_id": 192344, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to examine the increased usage, abuse potential, adverse effects, and withdrawal symptoms of kratom as an opioid substitute.", "results_summary": "The study noted kratom's opioid-like properties at high doses and its use to alleviate opioid withdrawal, but highlighted potential risks, adverse effects, and abuse potential.", "population_specificity": "Individuals with opioid use disorder or those seeking opioid substitutes (not explicitly specified).", "effective_dosage": "High doses (not explicitly quantified).", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:31.149095+00:00"}
{"study_id": 22532, "supplement_id": 1261, "safety_score": "30", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the contamination levels of kratom products, including microbial burden, toxic metals, and mitragynine content.", "results_summary": "All tested kratom products contained mitragynine (3.9-62.1 mg/g), most had microbial contamination (excluding Salmonella), and seven contained toxic metals (Ni, Pb, Cr).", "population_specificity": "Kratom products purchased from shops in the Western Suburbs of Chicago.", "effective_dosage": "Not specified (product testing, not human dosing).", "study_duration": "Not applicable (laboratory analysis).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:31.242613+00:00"}
{"study_id": 192340, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review preclinical evidence on mitragynine's potential as a novel medication-assisted therapy (MAT) for opioid use disorder (OUD).", "results_summary": "The abstract suggests mitragynine, the active alkaloid in kratom, acts as a partial mu-opioid agonist and may offer therapeutic potential for OUD, but its effectiveness, safety, and abuse liability remain controversial.", "population_specificity": "Preclinical studies (not specified for human populations).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:31.530371+00:00"}
{"study_id": 22531, "supplement_id": 1261, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the correlation between kratom dose and the required buprenorphine-naloxone dose for treating kratom-associated opioid use disorder (OUD).", "results_summary": "The study found a strong correlation (0.84) between kratom dose and buprenorphine-naloxone dose needed for treatment. Patients using <20 g/day of kratom could start with 4/1 mg-8/2 mg buprenorphine-naloxone/day, while those using >40 g/day required 12/3 mg-16/4 mg/day.", "population_specificity": "Patients with kratom-associated opioid use disorder (OUD).", "effective_dosage": "Kratom doses ranged from <20 g/day to >40 g/day; buprenorphine-naloxone doses ranged from 4/1 mg/day to 16/4 mg/day.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:31.759806+00:00"}
{"study_id": 192345, "supplement_id": 1261, "safety_score": "30", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to investigate whether Kratom use during pregnancy could lead to neonatal abstinence syndrome (NAS) in infants.", "results_summary": "The study reported a case of NAS in an infant born to a mother who used Kratom tea daily to self-treat opioid dependence, suggesting Kratom may pose risks similar to opioids during pregnancy. The findings highlight the need for awareness among pediatricians and parents about potential NAS risks associated with Kratom use.", "population_specificity": "Pregnant women using Kratom for opioid dependence and their infants.", "effective_dosage": "Daily Kratom tea ingestion (specific amount not provided).", "study_duration": "Duration of maternal Kratom use not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:32.689495+00:00"}
{"study_id": 22553, "supplement_id": 1262, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether krill oil supplementation could improve knee pain, stiffness, and physical function in adults with mild to moderate knee osteoarthritis, while also assessing its safety and impact on inflammatory markers.", "results_summary": "Krill oil supplementation led to modest improvements in knee pain, stiffness, and physical function compared to placebo, with no significant differences in NSAID use, serum lipids, inflammatory markers, or safety profiles between groups. The Omega-3 Index increased significantly in the krill oil group.", "population_specificity": "Adults aged 40-65 with mild to moderate knee osteoarthritis, regular knee pain, and low baseline omega-3 intake.", "effective_dosage": "4 g krill oil per day (containing 0.60 g EPA, 0.28 g DHA, and 0.45 g astaxanthin).", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:37.347516+00:00"}
{"study_id": 22554, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether krill oil could improve locomotion in acrylamide-impaired C. elegans by examining its effects on oxidative stress, energy metabolism, and lipid regulation.", "results_summary": "Krill oil enhanced locomotion (head thrashes and body bends) in impaired C. elegans by 16.4% and 19.3%, respectively, and reversed altered gene expressions related to neuron status, antioxidants, and energy metabolism. Lipidomics analysis showed krill oil restored metabolic changes, including downregulation of ceramides and fatty acids and upregulation of glycerophospholipids.", "population_specificity": "Acrylamide-impaired Caenorhabditis elegans (C. elegans)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:37.711437+00:00"}
{"study_id": 22506, "supplement_id": 1261, "safety_score": "40", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to review the pharmacological effects, therapeutic uses, and safety risks of Kratom, particularly its potential as an alternative to traditional opioid therapy.", "results_summary": "Kratom's main alkaloids, mitragynine and 7-OH-mitragynine, act on opioid receptors and other neurotransmitter pathways, offering analgesia and mild euphoria with lower respiratory depression risk than traditional opioids. However, it is associated with dependence, withdrawal symptoms, and serious adverse effects like liver toxicity and seizures.", "population_specificity": "Not specified (general review of existing data).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Potentiates toxicity of coadministered medications via cytochrome P450, P-glycoprotein, and UGT enzyme modulation.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:39.334300+00:00"}
{"study_id": 22555, "supplement_id": 1262, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Krill Oil inhibits tumor progression and tumor vascularization in bladder cancer cells and angiogenesis in HUVECs.", "results_summary": "Krill Oil repressed bladder tumor cell proliferation, invasion, and migration by modulating cell-cycle regulators and signaling pathways. It also significantly reduced tumor growth in xenograft mice and inhibited VEGF-induced angiogenesis in HUVECs.", "population_specificity": "Bladder tumor cell lines (MBT-2, T24), xenograft mice, and human umbilical vein endothelial cells (HUVECs).", "effective_dosage": "100-300 \u03bcg/mL (in vitro), 150-300 mg/kg (in vivo), 5-40 \u03bcg/mL (angiogenesis assays).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:40.266318+00:00"}
{"study_id": 22557, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of krill oil supplementation on muscle function and size in healthy older adults.", "results_summary": "Krill oil supplementation for 6 months significantly increased knee extensor maximal torque, grip strength, and vastus lateralis muscle thickness, along with improvements in erythrocyte fatty acid profiles (EPA, DHA, and omega-3 index). No effects were observed on other secondary outcomes like neuromuscular measures or quality of life.", "population_specificity": "Healthy men and women aged above 65 years with BMI <35 kg/m\u00b2 and low physical activity levels.", "effective_dosage": "4g/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:40.391816+00:00"}
{"study_id": 22556, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Antarctic Krill Oil (AKO) could protect against alcohol-induced liver injury by modulating bile acids metabolism and altering the gut microbiome.", "results_summary": "AKO supplementation significantly protected against alcohol-induced liver injury, reduced hepatic bile acids production, and altered gut microbiome composition in rats. The effects were dose-dependent, with higher doses showing more pronounced benefits.", "population_specificity": "Sprague-Dawley rats with alcohol-induced liver injury.", "effective_dosage": "Low-dose (100 mg/kg/d), high-dose (200 mg/kg/d), and AKO control (200 mg/kg/d).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:40.602911+00:00"}
{"study_id": 22559, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of krill oil (FJH-KO) on osteoarthritis progression in rat models and its impact on inflammation and apoptosis in chondrocytes and synovial cells.", "results_summary": "FJH-KO improved running speed, stride, and foot pressure in osteoarthritic rats and prevented cell death, suppressed matrix degradation, and reduced inflammation and apoptosis in treated cells.", "population_specificity": "MIA-induced osteoarthritic rats, H2O2- or LPS-treated primary chondrocytes, and the SW982 synovial cell line.", "effective_dosage": "150 mg/kg body weight", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:41.482981+00:00"}
{"study_id": 22558, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the anti-cancer effects of krill oil (KO) with oxaliplatin and identify the molecular mechanisms of KO in a mouse model of colorectal cancer (CRC).", "results_summary": "KO significantly reduced tumor weight and volume, comparable to oxaliplatin, and increased markers of apoptosis (cytochrome c, cleaved caspase-9/-3, DNA damage) while decreasing PD-L1, PD-L2, and HSP-70 expression in tumor tissues. KO combined with a half-dose of oxaliplatin showed similar efficacy.", "population_specificity": "Male Balb/c mice with orthotopically induced colorectal cancer.", "effective_dosage": "150 g/kg KO in diet, combined with 1.5 mg/kg oxaliplatin (half-dose) 3 times per week where applicable.", "study_duration": "6 weeks (3 weeks before and 3 weeks after CRC induction).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:41.869488+00:00"}
{"study_id": 22560, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether krill oil (KO) could prevent diabetic cardiomyopathy (DCM) in a mouse model of diabetes mellitus (DM).", "results_summary": "KO prevented cardiac fibrosis, apoptosis, and inflammatory cell infiltration in diabetic mice, reversed DM-induced profibrotic and proinflammatory gene expression, and attenuated oxidative stress by targeting SIRT3, PGC-1\u03b1, and NLRP3 inflammasome pathways.", "population_specificity": "Streptozotocin and high-fat diet-induced diabetic mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:45.188000+00:00"}
{"study_id": 22563, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether krill oil could protect against methamphetamine-induced memory deficits and explore the underlying molecular mechanisms.", "results_summary": "Krill oil significantly improved memory impairment induced by methamphetamine, likely through modulation of the MAPK signaling pathway and dopaminergic synapse pathways, as evidenced by changes in key protein expressions.", "population_specificity": "Methamphetamine-exposed mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:47.158810+00:00"}
{"study_id": 22561, "supplement_id": 1262, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a krill oil-derived \u03c9-3 formulation (CaPre) in reducing triglyceride levels in patients with severe hypertriglyceridemia.", "results_summary": "The study found that \u03c9-3-PL/FFA significantly reduced triglyceride levels by 26.0% at 12 weeks, with effects persisting at 26 weeks, and demonstrated a safety profile similar to placebo. No significant effects were observed on other lipid parameters like non-HDL-C, VLDL-C, HDL-C, or LDL-C.", "population_specificity": "Patients with severe hypertriglyceridemia (fasting TG levels 500-1500 mg/dL), including those on statins, fibrates, or other cholesterol-lowering agents, with a mean age of 54.9 years and 65.2% male.", "effective_dosage": "4 g/day", "study_duration": "26 weeks", "interactions": "Effects tended to be larger in patients taking statins or cholesterol absorption inhibitors at baseline.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:48.824666+00:00"}
{"study_id": 22562, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether catalase (CAT) is suitable for removing residual H2O2 in Antarctic krill oil emulsion without causing lipid oxidation and destabilization.", "results_summary": "The study found that CAT caused demulsification, stratification, and coagulation in krill oil emulsion within 2 days, likely due to lipid oxidation from the iron porphyrin group. Superoxide dismutase (SOD) and bovine serum albumin (BSA) showed minimal effects on emulsion stability.", "population_specificity": "Not specified (in vitro study on krill oil emulsion)", "effective_dosage": "1% (v/v) oil concentration, surfactant-to-oil ratio of 1:5 (v/v)", "study_duration": "2 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:48.933546+00:00"}
{"study_id": 22564, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of krill oil and fish oil on obesity-related parameters and gene expression in rats fed a high-fat diet.", "results_summary": "Krill oil showed moderate effects on lipid profile and liver fatty acid composition but had limited impact on obesity-related parameters like weight gain and glucose tolerance. It influenced gene expression differently than fish oil.", "population_specificity": "Male Wistar rats", "effective_dosage": "2.5% krill oil in high-fat diet", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:49.106257+00:00"}
{"study_id": 22565, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the combined effect of krill oil and probiotics (Bifidobacterium animalis F1-7) on improving atherosclerosis in mice.", "results_summary": "Krill oil, Bif. animalis F1-7, and their combination significantly reduced atherosclerotic plaque area, improved serum lipid and inflammatory factor levels, and regulated the FXR/CYP7A1 and TLR4/MyD88 pathways. The combination showed superior anti-inflammatory effects compared to krill oil alone.", "population_specificity": "ApoE-/- mice (a model for atherosclerosis).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:49.327638+00:00"}
{"study_id": 22567, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether krill oil (KO) could protect against high-fat diet (HFD)-induced cognitive impairment in mice by reducing oxidative stress in the brain.", "results_summary": "KO administration at 100, 200, or 500 mg/kg/d improved spatial memory and novel object cognition in HFD-fed mice, reduced oxidative stress markers (ROS, lipid peroxidation, NO), and enhanced learning and memory abilities.", "population_specificity": "Mice fed a high-fat diet for 10 weeks.", "effective_dosage": "100, 200, or 500 mg/kg/d", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:50.054600+00:00"}
{"study_id": 22566, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the long-term effects of krill oil (KrO) on obesity-associated inflammation, fatty acid composition, and metabolic health in tissues like epididymal white adipose tissue (eWAT) and the liver.", "results_summary": "KrO increased anti-inflammatory PUFAs and oxylipins (e.g., EPA, DHA, 18-HEPE) while reducing pro-inflammatory markers (e.g., arachidonic acid derivatives). It improved adipogenesis, reduced inflammation in eWAT and liver, and enhanced insulin sensitivity.", "population_specificity": "Mice fed an obesogenic diet (HFD) with fat derived mostly from lard.", "effective_dosage": "3% (w/w) KrO supplementation.", "study_duration": "28 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:50.851795+00:00"}
{"study_id": 22568, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether krill oil extract could inhibit human colorectal cancer cell migration and modulate EGFR signaling and PD-L1 expression.", "results_summary": "Krill oil extract significantly inhibited CRC cell migration and reduced the expression of EGFR, pEGFR, pERK1/2, pAKT, and PD-L1, suggesting potential anti-cancer properties.", "population_specificity": "Human colorectal cancer cells (DLD-1 and HT-29) in vitro.", "effective_dosage": "0.03 and 0.12 \u03bcL/100 \u03bcL for 8 or 24 hours.", "study_duration": "8 or 24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:53.319941+00:00"}
{"study_id": 22569, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Antarctic krill oil (FJH-KO) could mitigate osteoarthritis symptoms in a rat model induced by monosodium iodoacetate (MIA).", "results_summary": "FJH-KO supplementation reduced tissue damage, cartilage degeneration, and inflammatory markers (PGE2, IL-1\u03b2, IL-6, TNF-\u03b1) while increasing anabolic gene expression and decreasing catabolic and inflammatory gene expression in osteoarthritic rats.", "population_specificity": "MIA-induced osteoarthritic rats", "effective_dosage": "100 and 150 mg/kg body weight", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:54.833274+00:00"}
{"study_id": 22570, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether krill oil supplementation could improve depressive feelings and self-esteem in adolescents from the general population.", "results_summary": "The study found no significant effects of krill oil supplementation on depressive symptoms or self-esteem scores after one year, though adherence and drop-out issues may have influenced the results.", "population_specificity": "Adolescents from the general population", "effective_dosage": "400 mg EPA and DHA per day initially, increased to 800 mg after three months (Cohort I); 800 mg EPA and DHA per day from the start (Cohort II)", "study_duration": "One year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:56.900825+00:00"}
{"study_id": 22573, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the cognitive improvement effects and mechanisms of krill oil in an A\u03b225-35-induced Alzheimer's disease mouse model.", "results_summary": "Krill oil administration improved memory, learning, and cognitive function in the AD mouse model, as evidenced by enhanced performance in behavioral tests. It also reduced oxidative stress biomarkers and down-regulated apoptosis-related proteins in the brain.", "population_specificity": "A\u03b225-35-induced Alzheimer's disease mouse model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:57.077075+00:00"}
{"study_id": 22571, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Antarctic krill oil (AKO) enhances antioxidant capacities in coronary heart disease (CHD) patients via the KEAP1-NRF2 signaling pathway.", "results_summary": "AKO increased levels of EPA, DHA, KEAP1, and NRF2 while reducing oxidative stress markers (ROS, 8-OHdG, NO, MDA) and boosting antioxidant enzymes (SOD, GSH, GPx) in CHD patients compared to placebo. Serum EPA and DHA levels negatively correlated with ROS, which in turn negatively correlated with KEAP1-NRF2 levels.", "population_specificity": "100 coronary heart disease (CHD) patients", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:57.776289+00:00"}
{"study_id": 22572, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the in vitro anticancer activity of krill oil on mouse colon cancer cells, focusing on its effects on proliferation, colony formation, migration, and invasion.", "results_summary": "Krill oil inhibited proliferation and colony formation of CT-26 colon cancer cells by inducing G0/G1 cell cycle arrest and apoptosis. It also suppressed migration by disrupting microfilaments and microtubules and attenuated ERK signaling pathway activation.", "population_specificity": "Mouse colon cancer cells (CT-26)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:57.785314+00:00"}
{"study_id": 22574, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to understand the mechanisms by which Krill Oil modulates the gut microbiome and metabolome, and its role in resolving inflammation and promoting mucosal healing in inflammatory bowel disease (IBD).", "results_summary": "Krill Oil significantly reduced inflammatory markers in human macrophages, promoted M2 polarization, enhanced bacterial killing, and partially restored microbial dysbiosis and mucosal damage in animal models. It also suppressed histidine metabolism and reduced histamine biosynthesis.", "population_specificity": "Human macrophages (in vitro), pigs infected with Trichuris suis, and mice with Citrobacter rodentium-induced colitis (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effect with COX2 and IKK2 inhibitors noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:59.136350+00:00"}
{"study_id": 22575, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lipase-treated krill oil (KO) could increase brain DHA/EPA levels more effectively than untreated KO or fish oil (FO) by generating LPC-DHA/EPA.", "results_summary": "Lipase-treated KO significantly increased brain DHA and EPA levels (5- and 70-fold better than untreated KO) and elevated brain BDNF, while fish oil had no effect on brain DHA/EPA. LTKO also enriched liver DHA/EPA but was less effective than untreated KO and FO in adipose tissue and heart.", "population_specificity": "2-month-old mice", "effective_dosage": "Not specified", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:59.709993+00:00"}
{"study_id": 22577, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether 2 g/day of krill oil reduces knee pain and effusion-synovitis size in older adults with clinical knee osteoarthritis and knee effusion-synovitis.", "results_summary": "The study found that krill oil reduced knee pain and systemic inflammation, with primary outcomes focusing on changes in pain and effusion-synovitis size over 24 weeks. Secondary outcomes included pain improvement at various intervals, suggesting potential benefits for disease modification in osteoarthritis.", "population_specificity": "260 patients with clinical knee osteoarthritis, significant knee pain, and effusion-synovitis visible on MRI, recruited across five Australian cities.", "effective_dosage": "2 g/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:03.994112+00:00"}
{"study_id": 22578, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether krill oil could mitigate iron overload-induced toxicity in the liver and spleen.", "results_summary": "Krill oil improved microscopic features of liver and spleen, reduced elevated serum markers (transaminases, ALP, LDH, iron, ferritin), increased albumin, restored oxidant-antioxidant balance, and modulated HO-1, Nrf2, and MMP9 expression.", "population_specificity": "Rats with iron overload-induced toxicity", "effective_dosage": "40 mg/kg", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:04.287349+00:00"}
{"study_id": 22576, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-osteoarthritic effects of FlexPro MD\u00ae (containing krill oil, astaxanthin, and hyaluronic acid) in a rat model of osteoarthritis.", "results_summary": "FP-MD significantly reduced joint pain, cartilage destruction, and inflammatory biomarkers (COMP, CTX-II, TNF-\u03b1, IL-1\u03b2, IL-6) while also lowering mRNA expression of inflammatory mediators (iNOS, COX-2) and matrix-degrading enzymes (MMP-2, MMP-9). The findings suggest FP-MD may help manage osteoarthritis symptoms and slow disease progression.", "population_specificity": "Rats with monosodium iodoacetate (MIA)-induced osteoarthritis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "7 days pre-MIA administration and 21 days post-MIA administration (total 28 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:04.917583+00:00"}
{"study_id": 22580, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anti-aging effects of krill oil on d-galactose-induced brain aging in mice and explore the underlying mechanisms via proteomics and gut microbiota analysis.", "results_summary": "Krill oil reduced expression of certain phosphoproteins and proteins in the calcium signaling pathway, increased dopamine concentrations in serum and brain, and improved gut microbiota by reducing tyrosine-consuming bacteria while increasing Lactobacillus spp. and short-chain fatty acid producers.", "population_specificity": "Mice with d-galactose-induced brain aging", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:06.332898+00:00"}
{"study_id": 22582, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether co-treatment with krill oil and cotinine could prevent the adverse effects of prolonged restraint stress in mice, particularly focusing on depressive-like behavior and cognitive impairment.", "results_summary": "The study found that krill oil combined with cotinine effectively prevented astrocyte loss, depressive-like behavior, and cognitive impairment induced by restraint stress. The combination was more effective than cotinine alone in mitigating depressive-like behavior.", "population_specificity": "Mice subjected to prolonged restraint stress.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:06.629634+00:00"}
{"study_id": 22581, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of one year of krill oil supplementation on cognitive performance in adolescents with a low Omega-3 Index (O3I \u2264 5%).", "results_summary": "Krill oil supplementation led to a small but significant increase in mean O3I, but few participants reached the intended O3I range (8-11%). There was no significant effect on neurocognitive test scores, nor a relationship between O3I and cognitive performance.", "population_specificity": "Adolescents with a low Omega-3 Index (O3I \u2264 5%).", "effective_dosage": "400 mg EPA + DHA per day (Cohort I) or 800 mg EPA + DHA per day (Cohort II).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:06.647612+00:00"}
{"study_id": 22579, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the anti-proliferative efficacy of krill oil's free fatty acids extract (FFAE) with Oxaliplatin on colorectal cancer (CRC) cells and investigate its molecular mechanisms, focusing on the intrinsic mitochondrial death pathway.", "results_summary": "FFAE of krill oil, EPA, and DHA significantly inhibited CRC cell proliferation, increased reactive oxygen species (ROS) formation, and activated caspase-3/9, achieving effects comparable to Oxaliplatin. The anti-proliferative effects were linked to changes in mitochondrial membrane potential.", "population_specificity": "Human (DLD-1, HT-29, LIM-2405) and mouse (CT-26) colorectal cancer cell lines.", "effective_dosage": "FFAE of krill oil (0.06\u20130.12 \u03bcL/100 \u03bcL), EPA (0.13\u20130.52 \u03bcM), and DHA (0.06\u20130.26 \u03bcM).", "study_duration": "24\u201348 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:07.378062+00:00"}
{"study_id": 22583, "supplement_id": 1262, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate how krill oil supplementation affects plasma metabolites related to choline oxidation and tryptophan degradation pathways in healthy volunteers.", "results_summary": "Krill oil supplementation significantly increased fasting plasma choline, betaine, dimethylglycine, and sarcosine levels but did not affect metabolites of the tryptophan-kynurenine-nicotinamide pathways or vitamins.", "population_specificity": "17 healthy volunteers aged 18-36 years.", "effective_dosage": "4.5 g krill oil per day (providing 833 mg \u03c9-3 PUFAs and 1750 mg phosphatidylcholine).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:09.159595+00:00"}
{"study_id": 22585, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of intranasal krill oil, alone and in combination with cotinine, on depressive-like behavior and fear extinction in mice.", "results_summary": "Intranasal krill oil slowed fear extinction and was less effective than cotinine formulations in reducing depressive-like behavior and fear consolidation. No significant positive effects were observed with krill oil alone.", "population_specificity": "C57BL/6 mice subjected to fear conditioning.", "effective_dosage": "Not specified", "study_duration": "Short-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:11.698483+00:00"}
{"study_id": 22584, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of krill oil, lean and fatty fish, and high-oleic sunflower oil with astaxanthin on gene expression related to glucose and lipid metabolism and inflammation in humans.", "results_summary": "Krill oil altered the mRNA expression of multiple genes involved in glucose and cholesterol metabolism and \u03b2-oxidation, with more significant changes than fish but fewer than HOSO. No differences were observed in circulating inflammatory markers between groups.", "population_specificity": "Healthy men and women aged 18-70 years with fasting TAG of 1.3-4.0 mmol/l.", "effective_dosage": "Weekly intake of 4654 mg marine n-3 fatty acids from krill oil.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:12.955025+00:00"}
{"study_id": 22590, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether krill oil supplementation alters gut microbiota structure during obesity alleviation in mice.", "results_summary": "Krill oil supplementation attenuated weight gain, improved lipid profiles, and shifted gut microbiota structure toward that of control mice, with specific microbial changes linked to obesity-related parameters.", "population_specificity": "ICR mice fed a high-fat diet.", "effective_dosage": "Not specified.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:14.427210+00:00"}
{"study_id": 22587, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of Antarctic krill oil (AKO) against Alzheimer's disease (AD) by assessing cognitive function, anxiety, and oxidative stress in SAMP8 mice.", "results_summary": "AKO improved learning, memory, and anxiety in SAMP8 mice, reduced A\u03b2 accumulation in the hippocampus, and ameliorated oxidative stress in the brain by lowering MDA and 8-oxo-G levels while increasing SOD and GSH-Px activities.", "population_specificity": "Senescence-accelerated prone mouse strain 8 (SAMP8) mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:14.748619+00:00"}
{"study_id": 22589, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine how different doses of krill oil modulate gut microbiota in different gastrointestinal tract locations and alleviate hyperlipidemia.", "results_summary": "Krill oil treatment altered microbial communities in the ileum and colon, with low-dose krill oil shifting colon microbiota structure from high-fat diet (HFD) to control-like patterns, while high-dose krill oil showed intermediate effects. The study identified specific responsive genera and operational taxonomic units (OTUs) in both locations.", "population_specificity": "Not specified (animal study inferred from dosage units).", "effective_dosage": "100 mg/kg/day (low dose), 200 mg/kg/day (moderate dose), 600 mg/kg/day (high dose).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:15.558610+00:00"}
{"study_id": 22588, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether krill oil has anti-inflammatory, antioxidative, and anti-amyloidogenic effects in an Alzheimer's disease mouse model.", "results_summary": "Krill oil treatment prevented LPS-induced memory loss, reduced oxidative stress markers (ROS, malondialdehyde), suppressed neuroinflammation (iNOS, COX-2), and inhibited amyloid beta peptide generation by downregulating APP and BACE1 expression. EPA and DHA from krill oil also dose-dependently reduced LPS-induced inflammatory markers in microglial cells.", "population_specificity": "Alzheimer's disease mouse model (LPS-injected mice) and cultured microglial BV-2 cells.", "effective_dosage": "80 mg/kg/day for mice; 50 and 100 \u00b5M for EPA and DHA in cell culture.", "study_duration": "One month for mice; seven daily LPS injections.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:16.661705+00:00"}
{"study_id": 22591, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether krill oil alters gut microbiota structure during hyperlipidemia treatment and its dose-dependent effects on metabolic outcomes.", "results_summary": "Krill oil reduced weight gain, liver index, and lipid concentrations in a dose-dependent manner, with high-dose treatment showing unique gut microbiota changes and combined benefits for hyperlipidemia and obesity.", "population_specificity": "72 mice fed a high-sugar-high-fat diet.", "effective_dosage": "Low (100 \u03bcg/g\u00b7d), moderate (200 \u03bcg/g\u00b7d), and high (600 \u03bcg/g\u00b7d) doses.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:17.654885+00:00"}
{"study_id": 22592, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of krill oil supplementation on plasma lipid concentrations through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "Krill oil supplementation significantly reduced LDL cholesterol and triglycerides while increasing HDL cholesterol, though its effect on total cholesterol was not statistically significant.", "population_specificity": "662 participants across 7 randomized controlled trials (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "At least 2 weeks of supplementation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:19.830515+00:00"}
{"study_id": 22593, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory and LPS-inactivating properties of krill oil (KO) emulsion in human macrophages in vitro.", "results_summary": "KO emulsion inhibited LPS binding to TLR4 by 50-100% at concentrations of 12.5-50 \u00b5g/mL and reduced TNF-\u03b1 release by 30-75% at the same concentrations compared to LPS treatment alone. The study concluded that KO emulsion influences LPS-induced pro-inflammatory activation of macrophages, likely due to LPS binding inactivation.", "population_specificity": "Differentiated THP-1 macrophages (in vitro human cell line).", "effective_dosage": "12.5 \u00b5g/mL, 25 \u00b5g/mL, and 50 \u00b5g/mL.", "study_duration": "Not specified (in vitro study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:21.766540+00:00"}
{"study_id": 22596, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether krill oil administration could improve subjective symptoms of mild knee pain in adults.", "results_summary": "Krill oil significantly improved knee pain during sleep and standing, as well as the range of motion in both knees, compared to placebo. It also increased plasma EPA levels and the EPA/AA ratio.", "population_specificity": "Adults aged 38-85 with mild knee pain attending the Fukushima Orthopedic Clinic in Japan.", "effective_dosage": "2 g per day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:22.929125+00:00"}
{"study_id": 22595, "supplement_id": 1262, "safety_score": "85", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine whether an omega-3 rich phospholipid preparation from krill oil could improve cardiovascular disease risk factors, such as cholesterol levels, in dyslipidemic non-human primates.", "results_summary": "The study found that intermediate and high doses of the krill oil preparation reduced total cholesterol, LDL-cholesterol, and triglycerides while increasing HDL-cholesterol and apolipoprotein A1, with no effects on diabetes or inflammatory markers. No safety concerns were reported.", "population_specificity": "Dyslipidemic non-human primates with naturally occurring type-2 diabetes.", "effective_dosage": "50, 150, and 450 mg phospholipids/kg/day, administered daily.", "study_duration": "12 weeks (each dose level given for 4 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:23.174428+00:00"}
{"study_id": 22586, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether dietary supplementation with krill oil (KOC) and/or buttermilk fat globule membranes (BMFC) could improve insulin signaling, mitochondrial activity, and synaptic signaling in aged rats, potentially delaying cognitive decline.", "results_summary": "The combination of KOC and BMFC improved peripheral insulin sensitivity and increased intracellular ATP levels in the hippocampus, along with elevated BDNF levels, suggesting benefits for neuronal health and synaptic plasticity. No significant effects were observed in the cerebral cortex.", "population_specificity": "Aged rats", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:23.237085+00:00"}
{"study_id": 22594, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of increasing doses of omega-3 rich phospholipids from krill oil on erythrocyte fatty acid composition and plasma endocannabinoid levels in non-human primates.", "results_summary": "The study found that krill oil supplementation increased EPA and DHA levels in erythrocyte membranes while decreasing omega-6 polyunsaturated fatty acids, without altering saturated fatty acids. Plasma endocannabinoid changes mirrored these shifts, with reductions in arachidonic acid-derived mediators and increases in EPA-derived metabolites.", "population_specificity": "Diabetic, dyslipidemic non-human primates (6 subjects, 3 control, 3 treated).", "effective_dosage": "50, 150, and 450 mg phospholipids/kg/day, each dose administered for four weeks.", "study_duration": "12 weeks of treatment plus 8 weeks post-treatment observation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:23.874167+00:00"}
{"study_id": 22598, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the influence of increasing Omega-3 Index (via EPA+DHA supplementation) on cognitive functioning, academic achievement, and mental well-being in typically developing adolescents.", "results_summary": "The abstract does not provide specific results regarding the effects of the supplementation, only the study design and methodology.", "population_specificity": "Typically developing adolescents (age 13-15 years) with a low Omega-3 Index (<5%).", "effective_dosage": "400 mg EPA+DHA (cohort I) and 800 mg EPA+DHA (cohort II) daily.", "study_duration": "52 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:25.444151+00:00"}
{"study_id": 22597, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether free fatty acid (FFA) extract of krill oil could inhibit proliferation and induce apoptosis in human colorectal cancer (CRC) cell lines, comparing its effects to fish oil and specific omega-3 fatty acids.", "results_summary": "Krill oil extract inhibited cell proliferation in all three CRC cell lines similarly to fish oil extract and induced significant apoptosis and increased mitochondrial membrane potential. EPA, a constituent of krill oil, also significantly reduced proliferation and induced apoptosis, while DHA and AA showed no significant effects.", "population_specificity": "Human colorectal cancer cell lines (HCT-15, SW-480, Caco-2).", "effective_dosage": "50, 100, 150, and 200 \u03bcM concentrations.", "study_duration": "48 hours for krill oil extract, up to 72 hours for EPA/DHA/AA.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:27.149338+00:00"}
{"study_id": 22599, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the short-term triglyceride-lowering efficacy of krill oil versus purified omega 3 ethyl ester PUFAs in mildly overweight hypertriglyceridemic subjects.", "results_summary": "Krill oil improved high-density lipoprotein cholesterol and apolipoprotein AI levels more than esterified omega 3 PUFAs and reduced hs-CRP more effectively, though esterified omega 3 PUFAs were more efficacious in lowering triglycerides.", "population_specificity": "25 moderately hypertriglyceridemic subjects (TG = 150-500 mg/dl), mildly overweight.", "effective_dosage": "500 mg twice a day.", "study_duration": "4 weeks per treatment phase.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:29.194222+00:00"}
{"study_id": 22600, "supplement_id": 1262, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine if krill oil supplementation could favorably affect plasma lipid parameters and other markers involved in atherosclerosis initiation and progression.", "results_summary": "Krill oil reduced plasma triacylglycerol, large VLDL/chylomicron particles, and the TAG/HDL cholesterol ratio. It also improved fatty acid profiles, antioxidant capacity, and anti-inflammatory indices without adverse effects on TMAO or carnitine levels.", "population_specificity": "17 healthy volunteers aged 18-36 (mean age 23 \u00b1 4 years).", "effective_dosage": "832.5 mg EPA and DHA per day.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:30.614056+00:00"}
{"study_id": 22601, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of krill oil supplementation on cardiovascular disease risk factors and blood glucose control in participants with type 2 diabetes.", "results_summary": "Krill oil supplementation for 4 weeks improved endothelial function and reduced blood C peptide levels and HOMA scores compared to olive oil. After an additional 17 weeks, participants showed significant improvements in endothelial function and HDL levels.", "population_specificity": "Participants with type 2 diabetes.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Initial 4-week supplementation, optional 17-week extension.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:30.932190+00:00"}
{"study_id": 22603, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the oral bioavailability of EPA and DHA in krill oil versus fish oil (EE and TG forms) when administered at matched doses over four weeks.", "results_summary": "The study found no significant differences in plasma or RBC levels of EPA + DHA between krill oil and fish oil formulations when doses were matched, indicating comparable bioavailability. Bioavailability differed by less than 24% across groups, with krill oil showing slightly higher (but not statistically significant) plasma levels.", "population_specificity": "66 healthy adults (22 per treatment arm).", "effective_dosage": "1.3 g/d EPA + DHA (816 mg/d EPA + 522 mg/d DHA), administered as 6 capsules/day.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:32.331144+00:00"}
{"study_id": 22602, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to compare the bioavailability of EPA and DHA from krill oil (KO) and fish oil (FO) and assess their potential health effects on lipids, inflammatory markers, and cardiovascular disease risk.", "results_summary": "The study found that KO may have higher bioavailability of EPA and DHA compared to FO, but effects on lipids and inflammatory markers were limited. KO also regulated more metabolic pathways than FO, suggesting different biological effects.", "population_specificity": "Humans and animals (specific populations not detailed in the abstract).", "effective_dosage": "Not specified (same amounts of EPA and DHA from KO and FO were used in two human studies).", "study_duration": "Not specified (duration varied across studies).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:32.397424+00:00"}
{"study_id": 22604, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of krill oil to inhibit osteosarcoma cell proliferation and compare its effects to fish oil, EPA, DHA, and doxorubicin.", "results_summary": "Krill oil significantly inhibited osteosarcoma cell proliferation by 23%, 50%, and 64% at 24, 48, and 72 hours, respectively, outperforming fish oil (which showed no significant effect) and contrasting with EPA and DHA, which promoted cell proliferation. The inhibitory effect of krill oil was comparable to low doses of doxorubicin.", "population_specificity": "Human osteosarcoma cells in vitro.", "effective_dosage": "Not specified", "study_duration": "Up to 72 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:32.732262+00:00"}
{"study_id": 22605, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of krill oil (KO) and fish oil (FO) supplementation on glucose tolerance in obese New Zealand white rabbits.", "results_summary": "Krill oil supplementation significantly reduced fasting blood glucose and improved glucose tolerance, with effects comparable to fish oil. Gene expression changes in liver and skeletal muscle suggested improved insulin sensitivity and altered lipid metabolism.", "population_specificity": "Obese New Zealand white rabbits (male, castrated and non-castrated).", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:32.852463+00:00"}
{"study_id": 22606, "supplement_id": 1262, "safety_score": "30", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether krill oil, compared to pharmaceutical-grade fish oil (Lovaza), could extend lifespan and reduce mortality-related pathologies in long-lived male mice.", "results_summary": "Krill oil non-significantly shortened median lifespan by 4.7%, increased lung tumors (8.2-fold), and hemorrhagic diathesis (3.1-fold). It also modestly elevated bilirubin, triglycerides, and blood glucose levels.", "population_specificity": "Long-lived, male B6C3F1 mice starting at 12 months of age.", "effective_dosage": "1.17 g krill oil/kg diet (3% of total oil in diet).", "study_duration": "Administered daily until death (lifespan study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:36.011288+00:00"}
{"study_id": 22607, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the available human clinical studies on krill oil to assess its safety, efficacy, and market status as an alternative to fish oil for delivering omega-3 fatty acids EPA and DHA.", "results_summary": "The review highlights krill oil's potential benefits in managing hyperlipidemia, inflammation, and arthritis, and positions it as a viable alternative to fish oil due to its similar omega-3 content. The study summarizes findings from 10 peer-reviewed human clinical studies but does not provide detailed efficacy or safety outcomes.", "population_specificity": "Not specified (general human population inferred from clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:37.649563+00:00"}
{"study_id": 22608, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential of n-3/n-6 PUFAs and astaxanthin, found in krill oil, as nutraceuticals for combating neurodegenerative diseases linked to oxidative stress in the CNS.", "results_summary": "The study highlights the neurological benefits of n-3/n-6 PUFAs and astaxanthin, including anti-inflammatory and antioxidant effects that may prevent neurodegenerative processes and cognitive decline. Krill oil, containing these compounds, is presented as a promising natural combination for such applications.", "population_specificity": "Not specified (general human population implied)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:39.493356+00:00"}
{"study_id": 22611, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of krill oil on cognitive function in elderly subjects using psychophysiological methods.", "results_summary": "Krill oil significantly improved cognitive function, as evidenced by increased oxyhemoglobin concentrations during memory and calculation tasks and reduced P300 latency during a working memory task, outperforming both placebo and sardine oil.", "population_specificity": "45 healthy elderly males aged 61-72 years.", "effective_dosage": "Not specified.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:40.244663+00:00"}
{"study_id": 22609, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if daily krill oil supplementation reduces fasting serum triglyceride (TG) and lipoprotein particle levels in individuals with borderline high or high TG levels and low habitual fish intake.", "results_summary": "Krill oil supplementation resulted in a statistically significant 10.2% reduction in serum TG levels compared to placebo, without increasing LDL-C levels. The findings suggest krill oil may reduce cardiovascular risk, though individual TG variability indicates a need for further research with more measurements.", "population_specificity": "300 male and female subjects with borderline high or high fasting TG levels (150-499 mg/dL) and low habitual fish intake.", "effective_dosage": "0.5, 1, 2, or 4 g/day of krill oil.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:40.694427+00:00"}
{"study_id": 22613, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of krill oil on cardiac remodeling after experimental myocardial infarction (MI) in rats.", "results_summary": "Pretreatment with krill oil significantly attenuated left ventricular (LV) dilatation, reduced heart and lung weight, and lowered mRNA markers of LV stress, matrix remodeling, and inflammation. Krill oil also increased the proportion of n-3 PUFA in LV tissue, though no difference was observed between pretreatment and post-MI treatment groups.", "population_specificity": "Rats with induced myocardial infarction.", "effective_dosage": "Not specified.", "study_duration": "Pretreatment for 14 days before MI, followed by 7 weeks of post-MI treatment for one group.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:41.107748+00:00"}
{"study_id": 22610, "supplement_id": 1262, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of krill oil versus fish oil or placebo on plasma and red blood cell fatty acid profiles in healthy volunteers, focusing on omega-3 index and cardiovascular disease risk markers.", "results_summary": "Krill oil significantly increased plasma and RBC n-3 PUFA concentrations, reduced n-6:n-3 PUFA ratios, and improved the omega-3 index more effectively than fish oil. However, both krill and fish oil increased total and LDL cholesterol levels compared to placebo, with no changes in triglycerides or HDL cholesterol.", "population_specificity": "24 healthy volunteers", "effective_dosage": "600 mg of n-3 PUFA per day (in capsule form)", "study_duration": "4 weeks per treatment phase, separated by 8-week washout periods", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:41.224781+00:00"}
{"study_id": 22612, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of krill oil (KO) and fish oil (FO) on lipid homeostasis and inflammation in a mouse model of persistent low-grade exposure to hTNF-\u03b1, focusing on the structural forms of EPA and DHA (phospholipids vs. triacylglycerols).", "results_summary": "KO, containing n-3 PUFAs as phospholipids, effectively lowered plasma TAG and cholesterol, enhanced fatty acid \u03b2-oxidation, and improved carnitine turnover. FO improved cholesterol levels but was less effective than KO in reducing TAG. Inflammatory marker effects were minimal, with only slight changes in IL-17 (FO) and MCP-1 (KO).", "population_specificity": "Male C57BL/6 hTNF-\u03b1 transgenic mice fed a high-fat diet.", "effective_dosage": "Similar doses of n-3 PUFAs (EPA: 5.23-5.39 wt%, DHA: 2.82-2.36 wt% of total fatty acids).", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:43.349240+00:00"}
{"study_id": 22614, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of krill oil compared to fish oil on clinical and histopathological signs of inflammatory arthritis in an animal model.", "results_summary": "Krill oil significantly reduced arthritis scores, hind paw swelling, inflammatory cell infiltration, and synovial layer hyperplasia compared to control. It outperformed fish oil in reducing late-phase arthritis scores but did not modulate serum cytokine levels.", "population_specificity": "Collagen-induced arthritis susceptible DBA/1 mice (14 per group).", "effective_dosage": "0.44 g/100 g EPA + DHA in krill oil diet (ad libitum access).", "study_duration": "Throughout the study (duration not explicitly stated in abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:44.004403+00:00"}
{"study_id": 22615, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of Krill Oil on serum lipid levels in hyperlipidemia rats and its impact on the growth of human colon cancer cells (SW480).", "results_summary": "Krill Oil significantly reduced total cholesterol (TC), LDL-cholesterol (LDL-C), and triglycerides (TG) in hyperlipidemia rats, while HDL-cholesterol (HDL-C) remained unchanged. It also inhibited the growth of colon cancer cells in a time-dependent manner.", "population_specificity": "Hyperlipidemia rats and human colon cancer cells (SW480).", "effective_dosage": "Different doses (low, mid, higher) were used, but exact amounts are not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:46.272954+00:00"}
{"study_id": 22616, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of Neptune Krill Oil (NKO) on reducing C-reactive protein (CRP) levels in patients with chronic inflammation and its effectiveness in alleviating arthritic symptoms.", "results_summary": "NKO significantly reduced CRP levels by 19.3% after 7 days and up to 30.9% after 30 days, outperforming the placebo group. It also significantly improved WOMAC scores for pain, stiffness, and functional impairment within 7 days.", "population_specificity": "Patients with cardiovascular disease, rheumatoid arthritis, or osteoarthritis and elevated CRP levels (>1.0 mg/dl).", "effective_dosage": "300 mg daily", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:47.412622+00:00"}
{"study_id": 22617, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the effectiveness of Neptune Krill Oil (NKO) for managing premenstrual syndrome and dysmenorrhea and compare it with omega-3 fish oil.", "results_summary": "NKO significantly improved premenstrual syndrome and dysmenorrhea symptoms, reduced analgesic use, and was more effective than omega-3 fish oil.", "population_specificity": "70 reproductive-age women diagnosed with premenstrual syndrome (DSM-III-R criteria).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:48.122923+00:00"}
{"study_id": 71453, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the bioavailability of EPA/DHA from krill oil and other sources, comparing acute and chronic supplementation effects.", "results_summary": "The study found that phospholipid (PL) forms, such as those in krill oil, had higher bioavailability than some other forms (e.g., ethyl esters), but acute bioavailability differences did not always translate into long-term impacts. Methodological limitations and lack of standardized protocols were noted as barriers to reliable conclusions.", "population_specificity": "Human studies (acute and chronic supplementation)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:48.207369+00:00"}
{"study_id": 71455, "supplement_id": 1262, "safety_score": "75", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether krill oil supplementation (2 g/d) improved knee pain compared to placebo in individuals with knee osteoarthritis, significant knee pain, and effusion-synovitis.", "results_summary": "Krill oil did not improve knee pain compared to placebo, with no significant difference in pain reduction between groups. Adverse events were similar in both groups, with musculoskeletal and connective tissue disorders being the most common.", "population_specificity": "Individuals with clinical knee osteoarthritis, significant knee pain, and effusion-synovitis on MRI (mean age 61.6 years, 53% women).", "effective_dosage": "2 g/d", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:48.902332+00:00"}
{"study_id": 71459, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine whether Krill Oil (FlexPro MD) is an effective alternative for managing joint pain and inflammation in osteoarthritis patients.", "results_summary": "The abstract does not provide specific results regarding Krill Oil's effects.", "population_specificity": "Osteoarthritis patients seeking alternatives to nonsteroidal anti-inflammatory medicines or commercial supplements.", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:49.585114+00:00"}
{"study_id": 71458, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to assess whether krill oil supplementation (2.3 g of omega-3 daily) improved cognitive functioning, resilience, and mood in U.S. Army officers undergoing leadership training.", "results_summary": "The study did not find statistically significant associations between narcissism (measured by NPI) and success in the Army Ranger Course, but the abstract does not report specific outcomes related to krill oil's effects on cognitive functioning, resilience, or mood.", "population_specificity": "U.S. Army Infantry Basic Officer Leadership Course (IBOLC) officers intending to complete Ranger School (n=555).", "effective_dosage": "2.3 g of omega-3 (krill oil) daily.", "study_duration": "20 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:49.916859+00:00"}
{"study_id": 71460, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of Krill Oil, among other natural products, in repairing liver injury, improving fatty liver, and regulating liver immunity through gut microbiota modulation.", "results_summary": "The study suggests that Krill Oil, along with other natural products, can repair liver injury, improve fatty liver, and regulate liver immunity via multiple targets and pathways, with effects closely linked to gut microbiota modulation.", "population_specificity": "Not specified (general liver disease context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:52.049355+00:00"}
{"study_id": 71465, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize evidence on omega-3 phospholipids (primarily from krill oil) for obesity-related NAFLD and outline their potential in prevention/treatment.", "results_summary": "Preclinical studies indicate omega-3 phospholipids have strong antisteatotic effects in the liver, surpassing those of omega-3 triacylglycerols, with multiple mechanisms involving liver, adipose tissue, and gut. Clinical confirmation is needed.", "population_specificity": "Obesity-related NAFLD (preclinical focus, human clinical implications).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:55.168406+00:00"}
{"study_id": 71467, "supplement_id": 1262, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether omega-3 supplementation from krill oil could improve cognition and resilience among young military officers compared to a control.", "results_summary": "The study found no statistically significant group-by-time interactions indicating treatment effect on cognitive functioning, resilience, or mood. Poor compliance, evidenced by lower-than-expected omega-3 elevations in the treatment group, may have contributed to the lack of detectable response.", "population_specificity": "Young military officers (mean age 23.4 \u00b1 2.8, 98.6% male) entering the US Army Infantry Basic Officer Leaders Course (IBOLC).", "effective_dosage": "2.3 g omega-3 daily (via eight dietary supplements of krill oil).", "study_duration": "Approximately 20 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:55.798163+00:00"}
{"study_id": 71470, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the effects of bioactive fatty acids (including those in krill oil) on immune cells and inflammatory responses, as well as modern methods for their analysis.", "results_summary": "The abstract highlights that polyunsaturated fatty acids (PUFAs) like EPA and DHA from krill oil modulate immune function and reduce systemic inflammation by influencing pattern recognition receptors (PRRs). However, specific clinical efficacy data for krill oil is not detailed.", "population_specificity": "Not specified (general discussion, not a clinical study).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:56.262287+00:00"}
{"study_id": 71473, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the bioavailability of EPA and DHA from krill oil-derived OM3-PL/FFA versus FDA-approved OM3-EE in both fed and fasted states.", "results_summary": "OM3-PL/FFA showed significantly higher bioavailability of EPA and DHA in the fasted state compared to OM3-EE, and its absorption was less affected by food intake, suggesting a clinical advantage for patients on low-fat diets.", "population_specificity": "56 healthy adults", "effective_dosage": "Single 4-g dose", "study_duration": "Single administration (4-way crossover design)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:56.505606+00:00"}
{"study_id": 71471, "supplement_id": 1262, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the pharmacokinetic properties, dose proportionality, and safety of OM3-PL/FFA (a krill oil-derived formulation) in healthy subjects under different dietary conditions.", "results_summary": "The study found that OM3-PL/FFA reached steady state within 7-10 days, exhibited dose-proportional pharmacokinetics, and was well tolerated. Bioavailability was not significantly affected by meal fat content.", "population_specificity": "42 healthy volunteers following a Therapeutic Lifestyle Change (TLC) diet.", "effective_dosage": "Single and multiple oral doses of 1, 2, and 4 g/d.", "study_duration": "14 days of multiple dosing.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:56.728267+00:00"}
{"study_id": 71474, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to identify factors, including krill oil versus fish oil, associated with n-3 LCPUFA levels in adults.", "results_summary": "The study found inconclusive evidence regarding krill oil's association with n-3 LCPUFA levels compared to fish oil. Higher ALA consumption increased EPA but not DHA levels.", "population_specificity": "Adult non-pregnant humans", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:56.869935+00:00"}
{"study_id": 71475, "supplement_id": 1262, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety and tolerability of krill powder in humans and gather efficacy data on its impact on cardiovascular disease risk factors.", "results_summary": "The study found that krill powder was safe with no serious adverse events, though some mild gastrointestinal symptoms were reported. No significant changes were observed in blood pressure or lipid values.", "population_specificity": "Overweight subjects with mildly or moderately elevated blood pressure (n=35).", "effective_dosage": "4 g krill oil powder daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:57.423784+00:00"}
{"study_id": 71478, "supplement_id": 1262, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential role of \u1ff3-3 fatty acids (including krill oil) in reducing seizures, focusing on mechanisms, preclinical evidence, and clinical trial results.", "results_summary": "Preclinical studies support the role of \u1ff3-3 fatty acids in reducing seizures, but human clinical trials show limited evidence. Phase II RCTs suggest low to moderate doses may reduce seizures, but larger trials are needed for confirmation.", "population_specificity": "Animal models (mice, rats, dogs) and human participants in randomized controlled trials.", "effective_dosage": "Low to moderate dose (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:00.621623+00:00"}
{"study_id": 71479, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore drug repositioning strategies, including \"Big Data\" analysis and crowd-sourcing, to identify potential new treatments for systemic lupus erythematosus (SLE).", "results_summary": "The abstract discusses the need for new SLE treatments and proposes multi-pronged approaches like \"Big Data\" analysis and hypothesis-based drug repositioning, but does not mention Krill Oil or its effects.", "population_specificity": "Systemic lupus erythematosus (SLE) patients.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:02.346660+00:00"}
{"study_id": 71489, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether a nutraceutical containing Krill Oil, among other ingredients, could improve lipid profiles in psoriasis patients with metabolic syndrome when added to etanercept therapy.", "results_summary": "The study found statistically significant improvements in HDL cholesterol and triglyceride levels in the group receiving the nutraceutical compared to the etanercept-only group, suggesting a beneficial effect on lipid metabolism.", "population_specificity": "Patients affected by both psoriasis and metabolic syndrome (n=40).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:03.927697+00:00"}
{"study_id": 71481, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the molecular and clinical evidence for the benefits of different omega-3 fatty acid preparations, including krill oil, in the context of NAFLD.", "results_summary": "The abstract highlights that omega-3 fatty acids, including those from krill oil, show potential health benefits for NAFLD, though specific results for krill oil are not detailed. The review discusses the broader evidence supporting omega-3 supplementation in NAFLD management.", "population_specificity": "Individuals with non-alcoholic fatty liver disease (NAFLD) of varying severity, including steatosis, steatohepatitis, and fibrosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:04.084142+00:00"}
{"study_id": 71485, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of krill oil with other omega-3 supplements in increasing blood omega-3 levels and reducing cardiovascular disease risk.", "results_summary": "Krill oil (PL) showed the lowest increase in whole blood omega-3 levels among the tested supplements and was relatively unsuccessful in reducing cardiovascular disease risk compared to concentrated rTG fish oil.", "population_specificity": "Thirty-five healthy subjects.", "effective_dosage": "EPA of 150 mg, DHA of 90 mg daily.", "study_duration": "28-day intervention periods with 4-week washout periods.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:04.494977+00:00"}
{"study_id": 71484, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementation with a blend of krill and salmon oil (rich in EPA and DHA) affects insulin sensitivity in overweight men.", "results_summary": "The study found that krill and salmon oil supplementation unexpectedly decreased insulin sensitivity by 14% compared to the control oil, with a more marked reduction (27%) after controlling for the omega-3 index. This suggests krill oil may exacerbate diabetes and cardiovascular disease risk in overweight adults.", "population_specificity": "Overweight but otherwise healthy men aged 46.5 \u00b1 5.1 years with a BMI of 25-30 kg/m\u00b2.", "effective_dosage": "5 1-g capsules daily (total 5 g/day).", "study_duration": "8 weeks per treatment phase, with an 8-week washout period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:05.640060+00:00"}
{"study_id": 201073, "supplement_id": 1262, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether krill oil supplementation improves knee pain, stiffness, physical function, and lipid profiles in patients with knee pain.", "results_summary": "The study found no significant difference between krill oil and placebo for knee pain, stiffness, or lipid profiles, but a small improvement in knee physical function was observed.", "population_specificity": "Patients with knee pain (700 participants across five trials).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:05.695876+00:00"}
{"study_id": 22949, "supplement_id": 1263, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to elucidate the therapeutic mechanism of Compound Ku-Shen Injection (CKI) in treating liver cancer and explore its traditional Chinese medicine compatibility principles.", "results_summary": "The study identified 16 active components in CKI and 193 potential targets for liver cancer treatment, with key proteins like EGFR and ESR1 implicated. In vitro experiments showed that oxymatrine and matrine inhibited HepG2 liver cancer cell proliferation, and oxymatrine suppressed EGFR expression.", "population_specificity": "Liver cancer (HepG2 cell line in vitro)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:05.755272+00:00"}
{"study_id": 22951, "supplement_id": 1263, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of oxymatrine, a constituent of Ku shen, on cancer cells and its potential protective role against DMSO-induced toxicity.", "results_summary": "Ku shen demonstrated protective effects against DMSO-induced cell toxicity, and oxymatrine inhibited the G(2) and M phases of H4IIE cancer cells, suggesting anti-inflammatory and cytotoxic reduction properties.", "population_specificity": "H4IIE cancer cell line", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:09.217738+00:00"}
{"study_id": 22742, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a nondestructive method for predicting gel strength and classifying ethanol treatment levels in kudzu starch gels using microstructural analysis and NIR spectroscopy.", "results_summary": "The study found that ethanol treatment densified the starch gel network, and NIR spectroscopy combined with advanced data analytics effectively predicted gel strength and classified treatment levels, with the UVE-SVM model performing exceptionally well.", "population_specificity": "Not applicable (in vitro study on kudzu starch gels)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:10.397541+00:00"}
{"study_id": 22744, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ultrasonic pretreatment could enhance the binding of puerarin to kudzu starch and improve its functional properties.", "results_summary": "Ultrasonic treatment increased puerarin binding to kudzu starch, altered starch structure, and improved gel viscosity and elasticity. Hydrogen bonding was identified as the primary interaction mechanism.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:10.947856+00:00"}
{"study_id": 22748, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effects of Kudzu celery decoction (KCD) on sepsis-induced myocardial injury (SIMI) in mice.", "results_summary": "KCD treatment improved cardiac function, reduced myocardial fibrosis, oxidative stress, and inflammation in CLP-injured mice, demonstrating significant protective effects against SIMI.", "population_specificity": "BALB/c mice subjected to cecal ligation and puncture (CLP) to model sepsis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:12.391905+00:00"}
{"study_id": 22745, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to improve the functional properties of kudzu starch by applying six modification techniques to reduce its pasting temperature and increase solubility.", "results_summary": "Modified kudzu starches showed reduced crystallinity, lower pasting temperatures (except urea-alkaline treatment), and significantly higher cold-water solubility (>70% for extrusion-puffing methods vs. 0.11% for native starch). The apparent viscosity also decreased dramatically from 517.95 Pa\u00b7s to 0.47 Pa\u00b7s.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:12.538675+00:00"}
{"study_id": 22746, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the mechanism of action of Kudzu root in preventing and treating cerebral ischemia using network pharmacology and animal experiments.", "results_summary": "Kudzu root reduced neurological damage and cerebral infarction rates in rats with cerebral ischemia, primarily by mitigating excitatory amino acid toxicity and improving calcium overload. The study identified 84 active compounds and 34 protein targets linked to these effects.", "population_specificity": "Rats with middle cerebral artery occlusion (MCAO)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:12.560875+00:00"}
{"study_id": 22747, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if Pueraria montana (Kudzu) could protect rats from kidney tumors induced by diethylnitrosamine (DEN) and ferric nitrite (Fe-NTA).", "results_summary": "Pueraria montana treatment suppressed renal tumors, reduced tumor markers, improved antioxidant and phase enzyme levels, and decreased inflammatory cytokines and mediators. It also enhanced body weight and reduced renal weight and food intake.", "population_specificity": "Wistar rats", "effective_dosage": "12.5, 25, and 50 mg/kg orally", "study_duration": "22 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:13.223624+00:00"}
{"study_id": 22743, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of a kudzu leaf flavonoid (KLF) supplement on productive performance and egg quality in late-laying hens.", "results_summary": "KLF supplementation significantly reduced the deformity rate and increased eggshell strength, while also promoting beneficial gut microbiota (e.g., Bifidobacterium, Lactobacillus) and interacting with hypothalamus gene expression. The 0.6% KLF dosage showed the lowest deformed egg rate.", "population_specificity": "500-day-old Hy-Line Brown layer hens (360 total, divided into groups).", "effective_dosage": "0.2%, 0.4%, 0.6%, 0.8%, and 1.0% KLF supplementation.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:13.235133+00:00"}
{"study_id": 22751, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Kudzu resistant starch on insulin resistance, gut barrier function, and gut microbiota in type 2 diabetic mice.", "results_summary": "Kudzu resistant starch significantly reduced fasting blood glucose, improved lipid profiles, enhanced insulin signaling sensitivity, and restored gut microbiota balance in T2DM mice.", "population_specificity": "Type 2 diabetic mice", "effective_dosage": "Different doses (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:17.517525+00:00"}
{"study_id": 22749, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if superheated steam (SST) could prevent agglomeration of kudzu starch during rapid pasting with hot water while preserving its microstructure and rheological properties.", "results_summary": "SST at 20% moisture content reduced agglomeration from 42.20% to 2.97% without damaging starch microstructure or paste rheology, primarily by decreasing swelling power and increasing pasting temperature. Slight structural disruptions facilitated faster water absorption but were not the main prevention mechanism.", "population_specificity": "Not specified (laboratory study on kudzu starch)", "effective_dosage": "Not specified (moisture content of 10%\u201330% tested)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:17.670567+00:00"}
{"study_id": 22750, "supplement_id": 1264, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Kudzu root extract on bone and cartilage turnover, menopausal symptoms, and its safety across different dosing regimens in postmenopausal women.", "results_summary": "Kudzu root extract significantly reduced biomarkers of bone resorption and cartilage degradation, particularly with three-times-daily dosing, and improved menopausal symptom scores. It was well tolerated with no serious adverse events reported.", "population_specificity": "Fifty postmenopausal women (mean age 54.2 years) with at least mild menopausal symptoms.", "effective_dosage": "Five dose regimens, including two capsules three times a day (specific dosage amounts not detailed).", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:18.201128+00:00"}
{"study_id": 22752, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if Kudzu-leaf flavonoids (KLF) could effectively replace antibiotics in improving growth performance, gut health, and bacterial diversity in Yellow-feathered broilers.", "results_summary": "KLF supplementation improved feed efficiency, enhanced antioxidant capacity, promoted gut epithelial development, and increased beneficial probiotic bacteria diversity compared to the control group.", "population_specificity": "216 1-day-old male Yellow-feathered broilers", "effective_dosage": "Not specified", "study_duration": "56 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:19.581331+00:00"}
{"study_id": 22753, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the thermal inactivation kinetics of kudzu polyphenol oxidase (PPO) in model and food systems to understand its thermostability.", "results_summary": "PPO in kudzu tissue showed higher thermostability than in crude extract or purified fractions. Food constituents like pectin increased PPO's thermostability, with pectin providing the strongest protective effect against thermal inactivation.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:19.913946+00:00"}
{"study_id": 22754, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether enzymatic modification (\u03b1-amylase and transglucosidase) could improve the functional properties of kudzu starch for broader applications.", "results_summary": "The study found that enzymatic treatment reduced amylose content and molecular weight while increasing branching, solubility, and paste clarity, while decreasing viscosity and crystallinity. These changes enhanced the functional properties of kudzu starch, making it more suitable for large-scale use.", "population_specificity": "Not specified (in vitro study on kudzu starch)", "effective_dosage": "Not specified (enzymatic treatment times varied)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:20.563886+00:00"}
{"study_id": 22756, "supplement_id": 1264, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of kudzu leaf meal (KLM) as a dietary supplement on broiler performance, carcass characteristics, and organ parameters compared to alfalfa meal and a control diet.", "results_summary": "Broilers fed KLM had lower body weight, reduced feed consumption, and poorer feed conversion than the control group, but KLM showed potential as a safe protein supplement in poultry production, particularly in regions with limited commercial protein feed availability.", "population_specificity": "Male broiler chickens", "effective_dosage": "6% kudzu leaf meal added to the diet", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:20.846383+00:00"}
{"study_id": 22755, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the dry matter digestibility of corn stover and kudzu mixtures after solid-state fermentation with Pleurotus ostreatus for potential use in ruminant animal feed.", "results_summary": "The study found that mixtures of corn stover and kudzu, particularly the 25C:75K ratio, showed the highest in vitro dry matter digestibility after 77 days of fermentation, comparable to good-quality hay. Other mixtures also performed well, indicating potential for use in animal feed.", "population_specificity": "Ruminant animal feed (not human consumption).", "effective_dosage": "Varying ratios of corn stover and kudzu (100C:0K, 75C:25K, 50C:50K, 25C:75K, 0C:100K).", "study_duration": "0, 35, and 77 days of fermentation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:22.541223+00:00"}
{"study_id": 22758, "supplement_id": 1264, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Kudzu root extract inhibits HIV-1 entry into cells and its potential as a supplement to current antiretroviral therapy.", "results_summary": "Kudzu root extract significantly inhibited HIV-1 entry into various cell types without toxicity, blocked viruses resistant to Enfuvirtide, and showed synergistic or additive effects with existing antiretroviral cocktails. The mechanism involved inhibition of viral attachment to cell surfaces, independent of CD4 and co-receptors CXCR4/CCR5.", "population_specificity": "Cell lines, primary human CD4+ T lymphocytes, and macrophages.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:25.574113+00:00"}
{"study_id": 22759, "supplement_id": 1264, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adult kudzu bugs exhibit differential attraction to different soybean growth stages and whether this attraction is mediated by plant constitutive volatiles.", "results_summary": "The study found that significantly more adult kudzu bugs landed on soybean plants in the early reproductive stage (R1) compared to other stages, with females responding more strongly than males. The differential attraction was mediated by plant constitutive volatiles.", "population_specificity": "Adult kudzu bugs (Megacopta cribraria) and soybean plants (Glycine max).", "effective_dosage": "Not applicable", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:25.713646+00:00"}
{"study_id": 22757, "supplement_id": 1264, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety of Pueraria flower isoflavones (PFI) by evaluating estrogenic effects and hepatic CYP activity, and to compare its efficacy with soy isoflavones (SI) in reducing visceral fat and preventing bone loss in ovariectomized mice.", "results_summary": "PFI showed no estrogenic properties or effects on liver CYP activity at human-recommended doses. PFI did not reduce visceral fat or prevent bone loss in ovariectomized mice, whereas high-dose soy isoflavones (SI20) showed some bone-protective effects.", "population_specificity": "Normal female mice (Experiment 1) and ovariectomized mice (Experiment 2).", "effective_dosage": "Human-recommended PFI dose and 20x that dose (PFI20); human-recommended SI dose and 20x that dose (SI20).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:27.424140+00:00"}
{"study_id": 73152, "supplement_id": 1294, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to investigate insulin secretion in response to a ketogenic meal in healthy subjects.", "results_summary": "The study measured insulin secretion after a ketogenic meal in healthy individuals, but the abstract does not provide specific results on the effectiveness or outcomes of the diet.", "population_specificity": "12 healthy subjects (50% females, age 19-31 years, BMI 19.7-24.7 kg/m\u00b2)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:34.475559+00:00"}
{"study_id": 73146, "supplement_id": 1294, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the function of the ketogenic diet (KD) in Alzheimer's disease (AD) and outline its potential mechanisms as a therapeutic strategy.", "results_summary": "The study found that KD may benefit AD by improving mitochondrial function, optimizing gut microbiota, and reducing neuroinflammation and oxidative stress. Preclinical and clinical evidence suggests KD provides an alternative energy source and addresses AD pathophysiology.", "population_specificity": "Individuals with Alzheimer's disease (AD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:34.658249+00:00"}
{"study_id": 73154, "supplement_id": 1294, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the contribution of macronutrients and glycemic load to weight loss in a low-carbohydrate diet and examine the relationship between glycemic load and insulin secretion.", "results_summary": "The study found that carbohydrate-related measures (total amount, glycemic index, added sugar, and fiber) strongly associated with weight loss, while fat intake showed weak or no associations. Weight loss appeared driven by reduced glycemic load, particularly among those with high insulin secretion.", "population_specificity": "Adults aged 18-50 with overweight or obesity", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:35.020663+00:00"}
{"study_id": 73151, "supplement_id": 1294, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential health benefits of Christian Orthodox fasting, a dietary pattern low in refined carbohydrates and high in complex carbohydrates, on human health.", "results_summary": "Christian Orthodox fasting showed beneficial effects on glucose and lipid control, lower body mass, and caloric intake during fasting periods, but data on blood pressure were inconclusive. Dietary deficiencies were noted for calcium, vitamin B2, and vitamin D, but overall quality of life and mental health were good among fasters.", "population_specificity": "Monks and individuals practicing Christian Orthodox fasting.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:35.240366+00:00"}
{"study_id": 73153, "supplement_id": 1294, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of lifestyle interventions, including low-carbohydrate diets, on hepatic fat content and metabolism-related indicators in adults with metabolic associated fatty liver disease (MAFLD).", "results_summary": "The study found that a low-carbohydrate diet significantly improved hepatic fat content (HFC), triglycerides (TG), HDL, HbA1c, and HOMA-IR levels. It was more effective in reducing HFC compared to a low-fat diet.", "population_specificity": "Adults with obesity and metabolic associated fatty liver disease (MAFLD), 8% of whom also had diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:35.413193+00:00"}
{"study_id": 73149, "supplement_id": 1294, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate short-term metabolic changes induced by the ketogenic diet (KD) in patients with drug-resistant epilepsy and identify potential metabolites or pathways for new therapeutic targets.", "results_summary": "The KD increased ketone bodies, fatty acids, lipids, and related metabolites, including catabolites of branched-chain amino acids and structural analogues of \u03b3-aminobutyric acid and lactic acid, suggesting potential candidates for further anti-seizure medication development.", "population_specificity": "Patients with intractable epilepsy undergoing KD therapy (medium-chain triglyceride KD or modified Atkins diet using MCT oil).", "effective_dosage": "Not specified", "study_duration": "2-4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:35.504600+00:00"}
